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ABSTRACT 
Adolescent depression is a prevalent, serious health condition seen in primary care that is 
associated with many adverse physiologic changes, including cardiovascular disease. The 
aim of this integrative review was to examine those cardiovascular changes and determine 
whether preventive health checklists can help screen, identify, and ultimately prevent these 
changes. The eight studies selected for this review do not provide enough evidence to 
support the use of preventive health checklists as a way to prevent the cardiovascular effects 
of depression in adolescents. However, they form the basis for recommendations to be 
implemented in the primary care setting for ways to mitigate the risk of cardiovascular 
disease in adolescents with depression including using a multidisciplinary approach and 
guidelines for monitoring vital signs, weight, and bloodwork of these adolescents. Areas for 
future research are suggested and limitations of the evidence are also acknowledged. 
Keywords: adolescent, depression, cardiovascular disease, preventive health checklists, 
primary care, nurse practitioner  
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ABSTRACT 
Adolescent depression is a prevalent, serious health condition seen in primary care that is 
associated with many adverse physiologic changes, including cardiovascular disease. The 
aim of this integrative review was to examine those cardiovascular changes and ultimately 
treat depression in adolescents to prevent cardiovascular changes from occuring. The eight 
studies selected for this review do not provide enough evidence to support the use of 
preventive health checklists as a way to prevent the cardiovascular effects of depression in 
adolescents. However, they form the basis for an approach for comprehensive primary care 
that could help to mitigate the risk of cardiovascular disease in adolescents with depression , 
including using a multidisciplinary approach and guidelines for monitoring vital signs, 
weight, and bloodwork of these adolescents. Areas for future research are suggested and 
limitations of the evidence are also acknowledged. 
 
Keywords: adolescent, depression, cardiovascular disease, preventive health checklists, 
primary care, nurse practitioner 
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INTRODUCTION 
Adolescent depression is a serious health issue that has a high prevalence rate and a 
heavy burden of current and future morbidity (Thapar, Collishaw, Pine, & Thapar, 2012). In 
Canada, one in 20 young men and one in ten young women have experienced a major 
depressive episode while 40% of adolescents are sad for more than five days per year and 
22% are hopeless and stressed (Acharya & Phillips, 2014; Black, Hamilton, Platzer, & Seal, 
2014; Canadian Mental Health Association [CMHA], 2016). Additionally, 62% of 12-year-
old children have so much stress and despair that they feel like their life is not worth living 
(Black et al., 2014). Almost half of all mental health disorders in adults have been present 
since adolescence and nearly 75% by the age of 21 (Van Cleve, Hawkins-Walsh, & Shafer, 
2013). While the association between mental illness and physical health conditions such as 
cancer, heart disease, diabetes, arthritis, and asthma are well established and researched in 
adults (Miller, Constance, & Brennan, 2007) the future morbidities and negative health 
consequences of depression in adolescents are not as well known, although it has been 
suggested that future morbidities such as asthma, cardiovascular disease, and chronic 
headaches are associated with adolescent depression (Miller et al., 2007). This integrative 
literature review will examine what can be done by primary care practitioners who work with 
adolescents that have depression to mitigate their risk of future cardiovascular co-
morbidities.    
This topic arises from my experience working with adolescents suffering from 
depression. I work in acute care pediatrics and over the past several years I have noticed an 
influx of adolescents being admitted to hospital for depression. Many of these teenagers are 
admitted for stabilization after months of being depressed and on antidepressants. Most have 
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had multiple appointments with their primary care providers (PCP), yet while in hospital 
these adolescents have abnormal findings with their bloodwork and vital signs that show 
early hepatic, cardiac, or metabolic changes. The pediatricians and PCPs report that they do 
not know for how long the dysfunctions have been present and are unable to ascertain 
whether permanent changes have already begun to result in chronic illnesses or co-
morbidities for the adolescents.  
The role of the family nurse practitioner (FNP) is to work to promote, restore, and 
maintain health as well as prevent and treat illnesses for all patients, including adolescents 
with depression (College of Registered Nurses of British Columbia [CRNBC], 2016). It is 
well understood that patients who suffer from depression are at an increased risk of chronic 
illness due to poverty, social isolation, and unemployment, all of which are factors that are 
difficult, though not impossible, for NPs to influence or change (CMHA, Ontario, 2008). 
However, there may be other factors that NPs could influence or affect to decrease the 
likelihood of an adolescent with depression later manifesting a chronic illness. CMHA 
Ontario (2008) reported that people with serious mental illness who have access to primary 
care are not as likely to receive preventive health checks as their peers. The current national 
recommendation for preventive health checks for all adolescents is every one to two years 
(Greig et al., 2016), while the provincial recommendation is to have regularly scheduled 
checkups monitoring blood pressure, hearing, vision, weight, height, body mass index, and 
school and behavioural problems including severe mood swings, lack of pleasure or 
withdrawal from daily activities (Healthwise Staff, 2016). It is within this gap of higher 
morbidity and mortality rates for patients with mental health and whether preventive health 
checks would improve those outcomes, that this project will focus.    
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Adolescents with depression were selected for study because a review of the current 
literature suggests that much is known about the effects of depression on the physical health 
of adults but few studies have investigated the prevalence and association of mental health 
disorders and physiological health problems in adolescents (Aarons et al., 2008). In Canada, 
70% of patients with mental illness state that their symptoms began in childhood or 
adolescence, thus the identification and treatment of depression, as well as the prevention of 
associated chronic illnesses are best suited to be addressed in adolescence (Acharya & 
Phillips, 2014). 
CMHA Ontario (2008) identified several barriers to health care for people with 
mental illness, including difficulty finding a PCP because providers are reluctant to take 
patients with mental health diagnoses, stigma that leads to ‘diagnostic overshadowing’ of 
physical health conditions as psychologically manifested conditions, decreased access to 
specialist care and surgical treatment, the need for longer appointment times, and decreased 
preventive health checks within the primary care setting. It is opportune to focus on 
preventive health checks because their usefulness for illness prevention and health 
promotion. Preventive health checks are key tools in primary care praction components and 
are endorsed and recommended for use in adults by the College of Family Physicians of 
Canada for the provision of comprehensive, evidence-based care (CRNBC, 2016; Dubey & 
Glazier, 2006). The Canadian Task Force on Preventive Health Care (CTFPHC, 2016) 
provides many preventive health checklists for PCP to use in practice, one of those checklists 
screens for depression in adults over 18 who present to primary care but they are no 
preventive health checklists available for depression screening in adolescents, or to detect 
changes to the cardiovascular health of adolescents with depression.  Thus, there exists a gap 
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in the knowledge, preventive health checklists are recommended for use in primary care in 
Canada, and yet there is no clinically useful preventive health checklist for use in predicting 
the cardiovascular health of adolescents with depression.   
My research question is, would having preventive health checks during primary care 
visits improve later cardiovascular co-morbidities in adolescents living with depression? The 
purpose of my research question is to determine whether a preventive care checklist can 
enable NPs to provide comprehensive, evidence-based care to patients during periodic health 
examinations for the purposes of evaluating and mitigating the risk of future cardiovascular 
morbidities in adolescents with depression. 
This review begins with an in-depth discussion of the pathophysiology, clinical 
manifestations, and prevalence of adolescent depression; screening methods used for 
identifying both depression and cardiovascular disease; current treatment recommendations 
and risk of side effects for depression; cardiovascular risks related to depression; risk 
predictors currently used to identify cardiovascular risk in adolescents; the lack of preventive 
health checks in practice despite their support; and the relevance of treating adolescent 
depression in primary care. The methods section will detail how the literature search was 
conducted as well as how the articles for use in the review were graded. The findings will 
provide an analysis of the selected papers highlighting themes for further examination. 
Finally, the discussion section will provide a synthesis of the current evidence followed by 
recommendations for practice.     
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CHAPTER ONE 
Background 
 
 Depression is a common primary care concern affecting many Canadian youth. Major 
depressive disorder is a complex condition, affecting mental, social, and physical well-being. 
It causes not only well-known psychological symptoms, but many physical manifestations, 
including cardiometabolic changes. Lesser known is whether the physical signs and 
symptoms of depression signal cardiometabolic changes and whether they can be identified 
and addressed in the adolescent period during primary care visits. Thus, the objective of this 
integrative review is to determine whether preventive health checks can be used in 
adolescents with depression to avert future cardiovascular co-morbidities. This section will 
provide the reader with necessary background information on depression, cardiovascular risk 
predictors, and preventive health checks.      
Depression in Adolescence  
 Depression is a serious mood disorder that affects a person’s mental and physical 
health by causing persistent low mood; feelings of hopelessness, self-guilt, worthlessness, or 
despair; fatigue and decreased energy; changes in weight and appetite; difficulty 
concentrating or with memory; and loss of interest or pleasure in daily activities (Public 
Health Agency of Canada [PHAC], 2014). Criteria for the diagnosis of major depressive 
disorder (MDD) includes a change from baseline, either depressed mood or anhedonia, and 
the daily presence over the past two weeks of at least five out of nine symptoms: 1) feeling 
sad, tearful, or irritable; 2) decreased interest in daily activities; 3) weight change of at least 
five percent; 4) difficulty sleeping or sleeping too much; 5) agitation or somnolence; 6) 
fatigue and loss of energy; 7) feelings of worthlessness or guilt; 8) impaired social or 
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intellectual functioning; and 9) frequent suicidal ideation or thoughts (American Psychiatric 
Association, 2000). In order to make the diagnosis of depression the symptoms should cause 
significant distress to the daily functioning of the patient, be in the absence of other 
conditions that may mimic major depressive disorder, and not be in the presence of mania or 
hypomania (American Psychiatric Association, 2000).  
Adolescence represents a period of rapid physical growth and maturation as well as 
the social, intellectual, and emotional development of youth aged 13 to 18 (PHAC, 2012). 
Due to the changing nature of the adolescent mind and psyche, this is also a time when 
mental health disorders such as depression may emerge (PHAC, 2012; Waloszek et al., 
2015a). Depression often develops at the median age of 15 and is diagnosed based on similar 
clinical symptoms and criteria as depression in adults (Thapar, Collishaw, Pine, & Thapar, 
2012; Van Voorhees, Paunesku, Gollan, Kuwabara, Reinecke, & Basu, 2008). Depression is 
often a lifelong mood disorder that typically emerges at age 15 due to life-altering social and 
emotional changes and is marked by significant and pervasive physical and psychological 
symptoms. 
Prevalence. Adolescent depressive disorder is a serious health issue that has a 
prevalence rate of four percent worldwide and a heavy burden of current and future 
morbidity (Thapar et al., 2012). In Canada, five percent of young men and 12% of young 
women have experienced a major depressive episode while another 3 million adolescents are 
at risk of developing depression, potentially creating high economic and societal costs for 
Canadians (Acharya & Phillips, 2014; Canadian Mental Health Association [CMHA], 2016). 
Throughout the world, depression causes more disabling conditions and mortality in 
adolescents than any other medical condition (American Heart Association [AHA], 2015; 
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Waloszek et al., 2015a). Depression, with onset in adolescence, often perseveres into 
adulthood, meaning it has the potential to cause severe future chronic health disorders and 
comorbidities (de Ferranti & Newburger, 2016a; Suglia, 2015). The association between 
mental illness and future chronic physical health conditions such as cancer, heart disease, 
diabetes, arthritis, and asthma are well established and researched in adults (Miller, 
Constance, & Brennan, 2007). While the future morbidities and negative health 
consequences of depression in adolescents are not as well established, what is well known 
are the physical symptoms and psychological effects depression causes to all. 
Physiology. Depression is a “heterogenous disorder, involving a range of cognitive, 
somatic, and affective symptoms” (Bosch, Riese, Dietrich, Ormel, Verhulst, & Oldehinkel, 
2009, p.944). There are several proposed theories about the pathophysiology of MDD and 
how it affects the brain as well as the cardiovascular, metabolic and endocrine systems 
within the body. Many twin and sibling studies have shown that depression is 30 to 40% 
familial and that family history remains the strongest genetic predictor of depression (Hasler, 
2010). However, this means that 60 to 70% of depression is variable and susceptible to 
individual risk factors, including psychosocial stress, such as trauma, low income, low social 
support, and dysfunctional interpersonal relationships (Hasler, 2010).  Some of the individual 
physiological variations that may contribute to MDD are: altered transportation of the 
neurotransmitter system (monoamines, dopamine, serotonin), changes to the hypothalamic-
pituitary-adrenal axis (HPA), altered gamma-aminobutyric acid (GABA) concentrations in 
the prefrontal and cortex areas of the brain, hippocampal volume loss, and circadian 
abnormalities (Hasler, 2010).  
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 The importance of the physiological variations of depression is that many of them are 
also implicated in other co-morbidities, including cardiovascular disease (CVD). Those 
depressive physiological variations that share both familial and genetic pathways with CVD, 
and will therefore be examined in more detail, are the HPA axis dysfunction and changes to 
the neurotransmitter system. The hypothalamus is responsible for corticotropin-releasing 
hormone (CRH), which is discharged in response to stress and has been found to be 
exaggerated in individuals with depression (Hasler, 2010). Increased levels of CRH have 
been found to mimic many of the symptoms of MDD including alterations of appetite, sleep, 
and motor disturbances (Hasler, 2010). Additionally, CRH stimulates the adrenal gland to 
release cortisol, a corticosteroid that plays a part in increasing blood pressure, heart rate, 
lipid metabolism, and insulin levels (Hasler, 2010). Cortisol has been found in youth with 
somatic symptoms of depression and has been associated with low heart rate variability 
(HRV), a marker of cardiovascular dysfunction (Bosch et al., 2009).  Low variation in the 
interval between heart beats or low HRV is a dysfunctional regulatory process of the HPA 
axis as well as the sympathetic nervous system, a section of the autonomic nervous system 
that is responsible for constricting the blood vessels and increasing the force of cardiac 
contractions (Mulle & Vaccarino, 2013).  
 The neurotransmitters dopamine, serotonin, and noradrenaline are responsible for 
regulation of mood, concentration, and cognition; depression is thought to arise from either a 
depletion in or a decreased metabolism of these neurotransmitters (Hasler, 2010). Depression 
and its somatic and psychosocial symptoms may activate inflammatory mediators including 
cytokines, interleukin-6, and tumor necrosis factor, which has been shown to play an integral 
part in the dysregulation of the brain’s neurotransmitters and of the HPA axis (Hasler, 2010).  
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Depression is a complex pathophysiological process which contributes to the dysregulation 
of many different hormones and neurotransmitters and thus has multiple effects on the brain, 
metabolic, and cardiovascular systems. Depression contributes to cardiovascular risk through 
several pathophysiological functions including: increased rates of CRH from the 
hypothalamus, which stimulates the release of cortisol and contributes to alterations in blood 
pressure, lowered heart rate variability, lipid metabolism, and insulin levels; and decreased 
metabolism of the neurotransmitters serotonin, dopamine, and noradrenaline, which increase 
the production of the body’s stress and inflammatory mediators. Depression causes  the body 
to react to stress, thus changing the pathophysiological functions of the body. If these 
changes are left unchecked, it can lead to a chronic state of stress and increase the risk of 
cardiovascular morbidity. 
Screening for depression. Depression in adolescence often goes unrecognized and is 
therefore undertreated as compared to adults due to the fact that adolescents’ symptoms often 
fluctuate between irritability and sadness, which can be mistaken for normal teenage mood 
reactivity as opposed to depression (Thapar et al., 2012). This is important because even 
youth who receive treatment for MDD may progress to recurring or treatment-resistant 
depression in adulthood putting them at higher risk of morbidity and disabling conditions in 
the future (Van Voorhees et al., 2008). MDD is often cyclical, with periods of exacerbations 
and remissions happening frequently throughout the course of a lifetime. During periods of 
exacerbation, the levels of cortisol and other inflammatory mediators increase causing 
sympathetic nervous system dysfunction that over time can cause dysfunction and eventually 
permanent damage.  
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The significant negative health, disability, and societal costs of depression have 
prompted many experts including the American Academy of Pediatrics and the US 
Preventive Services Task Force to recommend depression screening annually for all 
adolescents (Kelly, 2016). The Guidelines and Protocols Advisory Committee (2010) 
recommend periodically screening children and youth for early depression in British 
Columbia while Greig et al. (2016) in a position statement for the Canadian Pediatric Society 
recommend following the US Preventive Services Task Force guideline of annual screening, 
provided there are systems for the treatment of depression in place. These differences of 
expert opinions results in a controversy of care for healthcare providers about how often 
routine screening for depression in adolescents should be done. Depression screening is 
important not only to identify those at highest risk of suicide, one of the leading causes of 
death for adolescents (Kelly, 2016), but also to identify those adolescents with depression 
that require further screening for CVD risk. Routine preventive health screening represents 
an important component of the adolescent periodic health encounter, not only for identifying 
depression, but for identifying it early enough to both effectively treat MDD, prevent suicide, 
and to significantly mitigate the risk of other long-term physical health sequelae, including 
cardiovascular disease.  
Treatment of Depression in Adolescents 
 Treatment of depression in adolescents is important to not only mitigate the physical 
and psychological effects of depression, but also to decrease the pathophysiological changes 
that occur during depression to also decrease the CVD and other morbidity risks. The 
symptoms of depression (see page 5) can cause many physical, social, and occupational 
impairments for adolescents, thus both the screening and the treatment of depression are 
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cost-effective ways of decreasing risk for CVD as well as decreasing expenses due to future 
comorbid health conditions (Miller et al., 2007; Vitiello et al., 2006). Adolescents are treated 
for depression most often because of impaired functioning; decreased quality of life; somatic 
symptoms; disruptive, antisocial, or aggressive behaviours; suicidal behaviours; 
hallucinations, delusions or abnormal perception; and hyperactivity, inattention, or 
concentration problems (Vitiello et al., 2006). Several longitudinal studies suggest that 60-
90% of MDD episodes in adolescence will go into remission within one year, however 
within five years 50-70% of patients will develop depressive symptoms again (Thapar et al., 
2012). Treating adolescent depression in the most effective manner is essential for 
decreasing the detrimental and persistent effects of depression as only one third of 
adolescents are able to return to their pre-depression level of functioning after three months 
of optimal treatment (Vitiello et al., 2006). This failure to return to the adolescents’ previous 
level of functioning perpetuates somatic symptoms and decreased quality of life that 
eventually leads to chronic medical conditions.  
Talking therapies. Basic interventions for any youth with MDD include having 
regular routines for sleep, eating, and exercise; having consistent parenting that maintains 
boundaries, limits, and consequences; and encouragement to avoid any substances or alcohol 
(Guidelines and Protocols Advisory Committee [GPAC], 2010). Options for moderate to 
severe persistent symptoms of MDD include cognitive behavioural therapy (CBT), 
interpersonal psychotherapy (IPT), and antidepressants including selective serotonin 
reuptake inhibitors (SSRIs) (GPAC, 2010; Thapar et al., 2012). Generally, CBT and IPT are 
first line treatment options and accepted as moderately effective for mild depression in 
adolescents (Thapar et al., 2012). Both first line treatment options can also be used as 
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adjuncts to antidepressant medication for more treatment-resistant depression (Thapar et al., 
2012). The biggest issue with CBT and IPT may not be their effectiveness or safety profile 
for the treatment of depression but rather the lack of qualified professionals to perform these 
specialized treatments and accessibility to these services in certain communities. Research 
has found that combining treatments used for depression has greater effectiveness for 
improving physical symptoms, quality of life, and overall functioning. These combined 
treatments include using both talk therapy and SSRIs, such as fluoxetine, as well as using 
physical activity interventions with a CBT approach (Parker et al., 2016; Vitiello et al., 
2006). Physical activity is a low-cost, effective adjunct treatment for depression that not only 
improves the somatic symptoms of MDD but may mitigate the risk of cardiometabolic risk as 
well.   
 SSRIs. SSRIs are the primary medication recommended for the treatment of 
adolescent mood disorders (Korczak, Canadian Pediatric Society Mental Health, & 
Developmental Disabilities Committee, 2013). SSRIs act to inhibit the transportation, impede 
the reuptake and increase the amount of serotonin in the brain (Korczak et al., 2013). They 
have been found to be moderately effective and more beneficial than harmful in children and 
youth (Korczak et al., 2013). However, while SSRIs have been approved for use in 
adolescents with depression by the Federal Drug Administration in the United States, they 
have not been approved by Health Canada (Garland, Kutcher, Virani & Elbe, 2016; Korczak 
et al., 2013). Yet, the Canadian Pediatric Society (CPS) supports the use of SSRIs for the 
treatment of MDD in adolescents and children (Korczak et al., 2013). Particularly, the CPS 
supports fluoxetine for treatment of MDD in adolescents as the majority of robust evidence 
has found fluoxetine to be generally well tolerated by both children and adolescents 
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(Korczak et al., 2013). Fluoxetine has been found to have some dose-dependent short-term 
side effects such as gastrointestinal upset, changes to sleep, headaches, restlessness, and 
appetite changes, all of which tend to disappear over time (Korczak et al., 2013). While 
fluoxetine has shown a 30-60% response rate in adolescence, the remission rates remain 
quite low, and there has yet to be consistently documented efficacy in trials (Garland et al., 
2016). Further, the number of adolescents that need to be treated (NNT) for one extra patient 
to achieve symptom control is four compared with a number needed to harm (NNH) of 50-
112 for a suicide related event, or NNH of four to ten for any side effects (Garland et al., 
2016; Korczak et al., 2013). Thus, there appears to be a favourable risk-benefit profile for 
fluoxetine, but insufficient or conflicting evidence in order to achieve Health Canada’s full 
support in the treatment of adolescent MDD.  
 When initiating treatment for adolescent depression close initial monitoring of 
symptoms, adverse effects, and cardiometabolic changes should be noted by PCPs. This 
monitoring should occur weekly for four weeks after the adolescent starts medication, 
followed by every two weeks for four weeks, once at 12 weeks, and then as needed but no 
less than yearly (Korczak et al., 2013). Treatment of MDD with SSRIs should begin with a 
goal of achieving full remission and reaching the lowest effective dosage over one to two 
weeks (Korczak et al., 2013). It is detrimental to have an adolescent remain on a starting 
dose of medication for a long period of time if he or she continues to display symptoms, 
therefore adolescents should have their SSRI increased until complete response is achieved 
(doses are often similar to that of adults) and then continue for six to 12 months to decrease 
relapse (Korczak et al., 2013). Optimizing medication and monitoring of treatment in 
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adolescent MDD is important for both minimizing adverse effects associated with SSRIs and 
also for decreasing the likelihood of developing chronic and persistent health conditions.  
Risks of SSRI use. Fluoxetine is the most commonly used medication in the 
treatment of adolescent depression; however, citalopram has also been approved for use by 
the FDA (Korczak et al., 2013). In addition to cardiovascular risks induced by stress and 
depression, some SSRIs, as well as second generation antipsychotics used to treat depression, 
can cause adverse cardiometabolic changes. Both the FDA and Health Canada have issued 
warnings about the potential QT-interval prolongation and risk of arrhythmia that can occur 
with doses of citalopram greater than 40mg per day (Korczak et al., 2013). Therefore, 
adolescents with congenital prolonged QT syndrome, heart disease, or liver impairment 
should not be treated with citalopram or should be treated with caution and monitored closely 
(Korczak et al., 2013). In addition to the cardiac side effects there has been much concern 
over the increased risk of suicidal ideation and activity with SSRIs. This risk can be 
mitigated both by reaching the minimum effective treatment dosages within one to two 
weeks and by close clinical monitoring of the adolescents over the first 12 weeks of 
treatment (Korczak et al., 2013). However, given that the NNH of suicide is between five to 
ten times more than the side effects of SSRIs, the risk of suicidality is higher in untreated 
depression than with SSRI treatment.    
Cardiovascular Health Risk in Depression 
 In addition to the cardiometabolic risk associated with some medications, depression 
has long been associated with adverse physical health outcomes and increased morbidity and 
mortality. In adolescents with depression these health outcomes include chronic conditions 
such as asthma and headaches as well as increased infectious diseases and problems with 
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weight (Aarons, Monn, Leslie, Garland, Lugo, Hough, & Brown, 2008; Miller et al., 2007). 
While many studies have outlined the relationship between cardiovascular disease (CVD) 
and depression in adults, only recently have researchers begun to question and identify 
whether depression in adolescence contributes to early markers of CVD as well. The 
bidirectional relationship between depression and CVD in adults results in higher rates of 
myocardial infarction (MI), increased mortality, and poor cardiovascular health due to 
cardiomyopathy and coronary artery disease (Elderon & Whooley, 2013; Miller et al., 2007; 
O’Neil et al., 2016b; Smolderen et al., 2015). As a result, there is an increased burden of 
CVD in healthcare, making it prudent to understand not only the traditional and non-
traditional contributory risk factors but also the physiologic changes these factors cause and 
when in the course of illness these changes occur.  
 In the past, CVD was considered a disease of middle-aged and older men that 
smoked, had high blood pressure and high cholesterol, were overweight or obese, and 
physically inactive. Today, CVD is not only the second leading cause of all deaths in Canada 
for men but for women as well (Statistics Canada, 2012). Additionally, statistics show that 
nine out of 10 Canadians have at least one risk factor for CVD while four out of 10 have at 
least three or more risk factors (Government of Canada, 2016). While the traditional risk 
factors of age, gender, family history, ethnicity, smoking, high blood pressure, diabetes, 
increased cholesterol levels, obesity, and physical inactivity remain important causes of 
CVD, there is increasing evidence that psychosocial factors, such as depression and stress 
contribute heavily to the occurrence of CVD and MI (Elderon & Whooley, 2013; O’Neil et 
al., 2016b).     
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 Contribution of depression to cardiovascular disease. There are multiple 
biological, behavioural and pharmocological factors that have been implicated in the 
bidirectional relationship between CVD and depression. Some of the behavioural factors 
include increased rates of smoking, poor diet, and physical inactivity which are more 
predominant amongst those with depression (Elderon & Whooley, 2013). The 
pharmacological factors include medication nonadherence and adverse effects from 
antidepressant medications (Elderon & Whooley, 2013). Finally, the biological links between 
depression and CVD include lower HRV, increased catecholamine levels, platelet activation, 
endothelial dysfunction, microvascular changes and overproduction of inflammatory 
mediators (Dhar & Barton, 2016; Elderon & Whooley, 2013; O’Neil et al., 2016a). 
 Although the clinical manifestations of CVD are not usually apparent until middle 
age, the atherosclerosis process begins in childhood and adolescence, first as fatty streaks, 
the precursor of plaque, in the aorta during childhood and then in the coronary arteries by 
adolescence (Rodrigues, Lima, Carvalho, Vera, Frota, Lopes, & Oliveria, 2015). Systemic 
arterial hypertension has been identified as a independent risk factor of CVD in adolescents, 
but is a more powerful risk factor when combined with a high BMI (Rodrigues et al., 2015). 
Other important adolescent CVD risk factors include family history, sedentary activity, and  
poor nutritional status (low fruit and vegetable consumption with high intake of fats and 
carbohydrates) (Rodrigues et al., 2015).    
    Behavioural factors. Depression can change a person’s cognitive functioning by 
decreasing their insight, judgement, and concentration, as well as affecting their sleep habits 
which may impair their energy (CMHA Ontario, 2008b). These changes to cognition and 
energy may negatively impact the person’s ability, initiative, and motivation to adopt healthy 
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behaviours such as not smoking, physical activity, and a healthy diet (CMHA Ontario, 
2008b). MDD can feel all-consuming, making accomplishing the smallest things difficult so 
people feel like they have little ability to make important health changes. Moreover, people 
may self-medicate with drugs and alcohol as a consequence or response to their depressive 
symptoms, which can also increase risk for CVD (CMHA Ontario, 2008b).    
 Biological factors. Inflammation, HPA axis activation, and sympathetic nervous 
system deregulation interact in a significant way to form a strong correlation between MDD 
and CVD. The effects of stress and depression on CVD include the development of 
endothelial dysfunction, platelet activation, glucose intolerance, increased visceral fat mass, 
and increased catecholamine, cytokine, and cholesterol production (Dhar & Barton, 2016; 
Elderon & Whooley, 2013). These biologic adaptations cause physiologic changes to the 
heart such as cardiac dysrhythmia, decreased blood flow, increased blood viscosity, 
atherosclerosis, hypertension, left ventricular hypertrophy, and decreased HRV, all risk 
factors contributing to cardiac mortality and MI (Dhar & Barton, 2016; Elderon & Whooley, 
2013). A healthy heart should have beat-to-beat variations in response to autonomic nervous 
system changes (Dekker, Crow, Folsom, Hannan, Liao, Swenne & Schouten, 2000). The 
input from the nervous system may include activation of the fight-or-flight system, 
communicating to the heart to either beat faster to pump more blood to the body or for the 
heart to slow down to conserve energy. In a person with depression, there is low HRV, 
meaning that the autonomic nervous system and the heart are less able to react  to changes in 
the environment, increasing cardiovascular risk and mortality (Dekker et al., 2000). While 
biologic and physiologic signs of inflammation have been linked to both CVD and MDD, 
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there are many different factors at work causing much overlap in the bidirectional 
relationship between the two illnesses.    
 Pharmacological factors. Antidepressants are the mainstay of treatment for 
depression, however, they do have several negative effects to the cardiovascular system 
including bradycardia (low heart rate), tachycardia (fast heart rate), low blood pressure, 
orthostatic hypotension, electrocardiogram changes, electrolyte abnormalities, decreased 
cardiac conduction and output, arrhythmias, and sudden cardiac death (Yekehtaz, Farokhnia, 
& Akhondzadeh, 2013). SSRIs are used as first-line treatment for depression because of their 
favorable side effect profile, as such adverse cardiovascular events are mild and less likely to 
occur at therapeutic levels (Yekehtaz et al., 2013). The most common cardiovascular side 
effects of SSRIs are mild bradycardia, orthostatic hypotension, and QT interval prolongation 
(Yekehtaz et al., 2013).  
Screening of cardiovascular risk factors. Recently, CVD has been found to be more 
prevalent amongst young women, aged 25-55 with a prior or concurrent history of depression 
(O’Neil et al., 2016b; Smolderen et al., 2015). Among women the more severe the prior or 
current depressive symptoms were, the greater the risk of CVD (O’Neil et al., 2016b). Yet, 
the risk of CVD was still present even if the women did not have a diagnosis of MDD but 
rather simply symptoms of depression (Elderon & Whooley, 2013). In fact, women with 
MDD or depressive symptoms have an increased risk of acute MI that is independent of other 
comorbid conditions, traditional cardiovascular risk factors, and previous health status 
(Elderon & Whooley, 2013; Smolderen et al., 2015). Given that most CVD-related deaths are 
preventable, assessment of both traditional and non-traditional, as well as modifiable and 
non-modifiable risk factors remains a priority.  
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Younger women are more likely to experience depressive symptoms over their 
lifetime and are more likely to die from CVD than ever before (O’Neil et al., 2016a). In 
Canada, females with depression are 80 percent more likely to have CVD than their non-
depressed counterparts (CMHA Ontario, 2008b). The American Health Association 
understands the significant role depression plays in cardiac mortality and nonfatal cardiac 
events, which made them add depression as a moderate risk factor for CVD (O’Neil et al., 
2016a; O’Neil et al., 2016b). Assessments for 10-year risk of CVD, such as the Framingham 
Risk Equation (FRE), are completed in primary care on both male and female patients aged 
30-74 by healthcare practitioners (D'Agostino, Vasan, Pencina, Wolf, Cobain, Massaro, & 
Kannel, 2008). Many primary care providers use risk prediction screening to help patients 
make informed decisions about the harms versus benefits of treatment for a certain condition , 
in the case of the FRE, the tool predicts absolute CVD risk of developing either a MI, angina, 
coronary insufficiency, heart failure, stroke, or intermittent claudication. Currently the FRE 
does not take into account the increased risk depression infers for CVD, despite many adult 
studies showing that depression is linked to CVD. Additionally, there is a growing amount of 
evidence that CVD begins in adolescence and shares many of the same pathophysiological 
changes as those seen in adults, including increased blood pressure and dyslipidemia, yet 
there is currently no tool for use by primary care providers to screen or predict 
cardiovascular risk in the adolescent population. This lack of cardiovasular risk screening 
appears to be largely due to the fact that there have been no long term studies done to 
identify which risk factors in youth are most predictive of future cardiovascular morbidity 
and a lack of consistency about which clinical manifestations confer the most risk from 
adolescence to adulthood (Bloetzer, Bovet, Suris, Simeoni, Paradis, & Chiolero, 2015).     
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Cardiovascular risk predictors in adolescence. The FRE predicts cardiovascular 
risk in adults based on an algorithm that accounts for age, total cholesterol, HDL, nontreated 
or treated systolic blood pressure (SBP), smoking, and diabetes (D’Agostino et al., 2008). 
While the same physiologic and biologic pathways and changes exist in the bidirectional 
relationship between depression and CVD in adolescents, cardiovascular risk predictors 
differ slightly in children and adolescents from that of adults. Early identification of CVD is 
becoming more imperative as the occurrence of cardiovascular mortality and non-fatal MIs 
in young men and women increases, and yet there are no validated CVD risk predictor tools 
for use in adolescence, further underlining the need for accurate prevention and intervention 
(Bauer, Marcus, El ghormli, Ogden, & Foster, 2014).  
The strongest predictor of cardio-metabolic risk in adolescents is increased body mass 
index (BMI), which is positively associated with elevated insulin levels, increased 
triglycerides, and decreased HDL levels, risk factors common with CVD in adults (Bauer et 
al., 2014). Studies have shown that having a BMI greater than the 95th percentile has a better 
predictive ability for cardiovascular risk than either waist circumference or waist-to-height 
ratio alone or in combination (Bauer et al., 2014). Additionally, elevated BMI is superior to 
distinguishing adolescents with a clustering of three or more cardiovascular risk factors, 
making it something that can be easily identified and monitored throughout adolescence and 
into adulthood (Bauer et al., 2014). Thus, adolescents with a BMI in the 95th or higher 
percentile are predicted to have at least three cardiovascular risk factors, which without 
intervention will carry on into adulthood inferring considerable risk of future CVD, including 
atherosclerosis. 
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Many studies have shown that risk factors measured in adolescents and early 
adulthood predict atherosclerosis in adults aged 30 to 45 years (Gidding et al., 2016). The 
physiological risk factors for atherosclerosis in middle age were measured using 
pathobiological determinants of atherosclerosis in youth (PDAY) scores, which measures 
age, gender, non-HDL cholesterol, HDL cholesterol, smoking, blood pressure, obesity and 
hyperglycemia (Gidding et al., 2016). As each risk factor is added, a one-point increase in 
the score is also added. An increase in the total score is associated with the odds ratio for an 
increase in atherosclerosis that would occur with one year of aging (Gidding et al., 2016). 
There is a strong association between the PDAY risk score measured in young adulthood and 
the presence and severity of coronary atherosclerosis in middle age (Gidding et al., 2016). 
Further, an increase in the PDAY risk score of young adults has a strong prediction for 
coronary artery calcium (CAC), a non-invasive measure of atherosclerosis (Gidding et al., 
2016). In fact, measuring risk for CAC between the ages of 18 and 30 better predicts CAC in 
middle age (Gidding et al., 2016). This suggests that atherosclerosis risk should be screened, 
assessed, and lowered in adolescence and early adulthood when progression of vascular 
lesions can be slowed or even stopped.         
Lack of Preventive Health Checks for Patients with Mental Illness 
 Due to the chronic nature of mental illness and the relationship between mental illness 
and chronic health conditions, there is a need for both chronic disease management but also 
prevention. While most mental illnesses are not preventable, the chronic diseases associated 
with mental illness can be mitigated, reduced, and perhaps even prevented, through a means 
of health promotion, disease prevention, access to primary care and continuity in care but 
only if those risks are targeted early enough in the course of the disease. Identifying which 
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specific morbidities an individual is most at risk for allows the healthcare professional to 
tailor which health promotion strategies the patient should focus on. Despite the fact that 
individuals with serious mental illness, including depression, have poorer health outcomes 
and higher mortality rates, people often lack access to preventive health screenings (CMHA 
Ontario, 2008a; CMHA Ontario, 2008b). Even patients with depression that have access to 
primary care are less likely to receive preventive health checks than those patients without 
mental illness (CMHA Ontario, 2008b).  
 Preventive care, or identifying those at risk of a disease but who have not yet been 
formally diagnosed with the disease, has been stressed as important for the health of all 
patients and touted as a foundation of primary health care (Lord, Malone, & Mitchell, 2010; 
Kelly, 2016). Preventive health checks are imperative for not only reducing mortality but 
also for increasing quality of life and reducing barriers to care (CMHA Ontario, 2008b; Lord 
et al., 2010). Preventive screening is well supported within Canadian healthcare for a variety 
of populations and diseases. The College of Family Physicians of Canada (2015) and the 
Canadian Task Force of on Preventive Health Care (CTFPHC, 2016) support preventive 
health checklists as a way to provide comprehensive, evidence-based care to patients. The 
principles of screening are to identify individuals who are at a higher risk of disease  or to 
identify a disease that has a high prevalence in a seemingly healthy population (Kelly, 2016). 
Also, preventive screening helps recognize individuals at risk of substantial morbidity and 
mortality if a disease goes untreated as well as the preclinical detection of a disease that may 
be detectable and improved, avoided, or treated more easily before the full course of the 
disease sets in (Kelly, 2016).  
23 
 
Historically, primary care providers have provided low to moderate rates of 
preventive health to patients due to decreased awareness of guidelines, lack of familiarity 
with implementing guidelines, lack of belief that health outcomes can be changed, and lack 
of visit time (Dubey, Mathew, Iglar, Moinnedin, & Glazier, 2006). This has changed in 
recent decades as evidenced by easily accessed standards and practice guidelines on CPC and 
specialist college and government websites (e.g. http://www2.gov.bc.ca/gov/content/health 
/practitioner-professional-resources/bc-guidelines). As an adjunct to guidelines, the use of 
preventive health checklists has been found to improve the delivery of preventive health care  
to a clinically significant degree and has therefore been endorsed as an important approach 
for the health maintenance and prevention of disease by the College of Family Physicians of 
Canada and the CTFPHC (Dubey et al., 2006). Preventive health checks should be done 
yearly as part of a patients’ physical health exam. However, preventive health checks can be 
used any time as a quick and efficient way of addressing the relevant and pertinent risk 
assessments of each patient. Both depression and CVD are important diseases with high 
morbidity and mortality rates, warranting preventive screening.  
 Screening for depression is recommended in children and adolescents between the 
ages of 10 and 18 every one to two years by the American Academy of Pediatrics and the 
Canadian Pediatric Society (CPS) (Greig et al., 2016; Kelly, 2016). The CPS (2016) and the 
Ontario Centre for Excellence for Child and Youth Mental Health (2016) recommend the 
following validated and reliable screening tools for use in diagnosing adolescents with 
depression: Patient Health Questionnaire (PHQ-9), Child Depression Inventory 2 (CDI-2), 
Beck Depression Inventory (BDI), Quick Inventory of Depressive Symptoms (QIDS), Mood 
and Feelings Questionnaire (MFQ), Reynolds Adolescent Depression Scale (RADS), and the 
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Kutcher Adolescent Depression Scale 6 (KADS-6). However, there is currently not enough 
evidence to provide clear guidelines around screening recommendations for pediatric and 
adolescent prevention of adult CVD including hypertension or dyslipidemia (de Ferranti & 
Newburger, 2016b). We do know that atherosclerosis can begin in childhood and 
adolescence and that certain youth are at increased risk for CVD based on their co-
morbidities, warranting screening for CVD in at least some of this population. While CVD 
screening and prevention in youth may not be well studied, CVD risk assessment in adults is, 
and includes the FRE. The FRE is an individual risk assessment tool widely used in current 
practice for the prevention of CVD as well as to help guide practice about when to 
appropriately treat patients to prevent future cardiovascular events (de Ferranti & 
Newburger, 2016b). The FRE is recommended by the College of Family Physicians of 
Canada and used as part of the preventive health checks for adults. Currently, the Canadian 
Pediatric Society (CPS) uses the Greig Record as a guide for preventive care visits in 
adolescents, however it does not include any recommendations around the screening of CVD 
in youth. Thus, a gap has been identified between the recommendations from the AHA to 
screen for cardiovascular risk in adolescents with depression and how this information is 
being translated into practice for use to screen and identify those adolescents most at risk.  
Additionally, international guidelines recommend that all patients prescribed 
medications for mental illness should have regular reviews of cardiovascular risk factors, 
including fasting glucose, lipid panel, and BMI (Osborn, Baio, Walters, Petersen, Limburg, 
Raine, & Nazareth, 2011). Osborn et al. (2011) found that patients with mental illness have 
decreased rates of BMI measurement, BP recording, cholesterol testing, and glucose levels. 
In fact, people with mental illness such as depression are half as likely to be screened for 
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CVD risk factors, as people without mental illness (Osborn et al., 2011). A comparative 
analysis of 26 different studies with 61 comparisons found that patients with mental illness 
were more likely to have inferior preventive health care in almost half of all comparisons, 
most apparent in osteoporosis screening, BP monitoring, vaccinations, mammography, and 
cholesterol testing (Lord et al., 2010). In adults with depression there was inferior preventive 
care for BP monitoring and cholesterol, important risk factors to monitor CVD risk (Lord et 
al., 2010). Annual preventive health screening, cardiovascular risk assessment, and health 
promotion are recommended for all patients with mental illness by the National Institute for 
Health and Clinical Excellence in Great Britain (Osborn et al., 2011). Preventive health 
checks, when based on the best available evidence, are important for reducing barriers to 
care, improving quality of life for patients with mental illness, and identifying risk factors for 
CVD, making them useful and pertinent tool of practice for primary care.     
Relevance to Scope of Practice and Role of NP 
Recognizing, diagnosing, intervening, and treating adolescent depression are very 
relevant to the NP role and scope of practice. The NP role in Canada blends nursing theory 
and experience with advanced education, autonomy, integrity, and responsibility to 
emphasize an evidence-based, holistic healthcare approach that focuses on health promotion, 
disease prevention, and partnership development (Canadian Nurse Practitioner Initiative 
[CNPI], 2006; College of Registered Nurses of British Columbia [CRNBC], 2016). NPs 
develop therapeutic relationships, provide quality healthcare, and integrate the diagnosis and 
treatment of illnesses for people of all ages, including children and youth, as well as all 
different types of populations, such as First Nations people, people with mental illness, 
people with substance abuse problems, and other marginalized peoples.  
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While the NP role is distinct and separate from other professionals, it serves to 
supplement and complement other roles, increasing access to primary care (CNPI, 2006). 
Increasing access to primary care NPs is integral to the healthcare system; it allows NPs to 
engage patients in their own care and involve them in the decision-making process, it creates 
valuable and trusting therapeutic relationships between the practitioner and patients all while 
reducing pressures on other areas of the healthcare system (Canadian Nurses Association 
[CNA], 2011). Many studies show the high value NPs contribute to primary care including 
providing care that is safe, effective, timely, equitable, patient-centred and efficient (Naylor 
& Kurtzman, 2010). Patient outcomes such as mortality, satisfaction, and physical and 
mental functioning is comparable to that of physicians (Naylor & Kurtzman, 2010). In fact, 
Naylor and Kurtzman (2010) found that patients who seek care from NPs had higher 
satisfaction, more time for consultations, and more investigations with no differences to 
processes of care or cost of resources. Primary care also provides an excellent opportunity to 
diagnose, treat, and manage chronic illnesses such as CVD and mental illness. NPs can 
assess and mitigate risk, provide advice about lifestyle modification, recommend treatment, 
prescribe medications, and intervene for many common diseases. Both CVD and depression 
are more prevalent in marginalized people, and because NPs are often employed in contexts 
that serve vulnerable and marginalized populations, the NP role and scope of practice help to 
decrease barriers and stigmas and provide high quality care, health promotion, and 
partnership development, NPs are in a position to provide excellent healthcare for patients 
with both mental illness and CVD.   
A study found that almost 80% of FNPs treat and manage mental illness in their 
primary care practices while less than ten percent of NPs are considered to have specialized 
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knowledge or practice in mental illness (Munro, 2015). Having NPs either provide primary 
care within a community mental health setting or alongside mental health providers results in 
a modest increase of the self-perceived health status and functioning of patients with mental 
illness (Rogers, Maru, Kash-MacDonald, Archer-Williams, Hashemi, & Boardman, 2016). In 
addition, NPs improved coordination of formal and informal information and communication 
about patients’ needs, as well as provision of health promotion, prevention, and wellness 
services critical to many mental health patients (Rogers et al., 2016). Furthermore, NPs are 
particularly helpful in providing primary care to mental health patients because of their 
knowledge about medical comorbidities as well as the mental and physical adverse effects 
that can arise from psychopharmacological treatments (Rogers et al., 2016).  
Primary health care and depression. Primary care and primary health care are two 
similar but distinct concepts often used interchangeably. Primary health care refers to 
universally accessible health care for individuals and families in the community that they live 
in, by means that are acceptable to them, and at a cost that the community and country can 
afford (Muldoon, Hogg, Levitt, 2006). Primary health care is often the point of first contact 
through public health initiatives such as public health clinics by individuals, families, and 
communities with the national health care system. The primary health care focus is on 
disease prevention and health promotion while bringing both medical and curative care, 
support and rehabilitation where it is needed (CNA, 2005; Muldoon et al., 2006). Primary 
health care attempts to incorporate not only the necessities of health but also the social, 
economic, and physical environments that affect health, while keeping the individual an 
active participant in shared decision-making with healthcare professionals (CNA, 2005). 
Primary care is the ‘first-line’ clinical services that provide entry into the healthcare system 
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and is typically person-focused, provider-driven care based in clinical diagnosis and 
treatment sustained over time (CNA, 2005; Muldoon et al., 2006). Thus, NPs are members of 
multi-disciplinary primary care teams, who aim to provide primary care to patients and 
families, including the adolescent population, while integrating a primary health care focus 
into their practice.   
The World Health Organization (WHO) and the World Organization of Family 
Doctors (WONCA) (2008) identified seven reasons why mental health is best treated within 
primary care: 1) the burden of mental illness is prevalent; 2) there is a bidirectional 
relationship between mental and physical health and illness; 3) there is a large treatment gap 
for mental illness; 4) using primary care for mental illness increases access; 5) primary care 
for mental health promotes respect of human rights and dignity by minimizing stigma and 
discrimination; 6) utilizing primary care for mental illness is affordable and cost effective; 
and 7) including mental health in primary care improves health outcomes. Essential 
components of primary care services for mental health include early identification of mental 
illness, effective treatment of common mental disorders, management of patients with stable 
mental health disorders, referral to higher levels of mental health care, and mental health 
promotion and prevention. Therefore, the healthcare needs of adolescents with depression 
can be appropriately addressed by family nurse practitioners within their practice (WHO & 
WONCA, 2008).  
In Canada, 70% of patients with mental illness state that their symptoms began in 
childhood or adolescence, thus the intervention and treatment of depression, as well as the 
prevention of associated chronic illnesses is best suited to be addressed in adolescence 
(Acharya & Phillips, 2014). Unmet mental health needs, including adolescent depression, are 
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a serious concern within primary care in both Canada and the United States. Integrated 
mental health care for adolescents with depression is supported by both the chronic nature 
and the high prevalence of mental illness in children and youth, barriers to access appropriate 
care, and that care cannot and should not be dichotomized into either mental health or 
physical health (Van Cleve et al., 2013). This is significant because both a system and 
healthcare providers are needed to address, diagnose, treat, and manage adolescents with 
depression and cardiovascular risk. Arguments for pediatric mental health to be supported 
and delivered both within primary care and by primary care providers, such as nurse 
practitioners include: the present and future lack of access to mental health specialists; the 
availability of screening tools and decision algorithms to diagnose and treat common 
pediatric mental illnesses; the avoidance of stigma and barriers to care; and the increasing 
availability of holistic, multimodal, and effective treatment options (Van Cleve et al., 2013).  
To this end, family nurse practitioners with education and practice in pediatric development, 
behaviour, and mental health conditions can provide much needed healthcare and access to 
mental health services for children and youth with mild to moderate mental illness (Van 
Cleve et al., 2013).  
Mental healthcare is best taken up in primary care because this model of care 
“addresses the needs of all patients upon first point of contact” (Van Cleve et al., 2013, 
p.244). Primary care provides the perfect framework for addressing the mental health needs 
of adolescents because of the development of a long-term relationship between the provider 
and family/patient which may allow the provider to recognize subtle signs, symptoms, and 
variations of behaviour, development, and mental illness sooner. The majority of parental 
concerns during the adolescent period are related to behaviour and psychosocial changes 
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(Van Cleve et al., 2013). Moreover, because only one in five children with mental health 
issues actually receive mental health care, often due to the stigma and inability to access 
primary care, it is important for the early identification of mental illness to improve 
outcomes for children and adolescents (Van Cleve et al., 2013). The frequency of childhood 
and adolescent primary care visits allow NPs to recognize adolescents at risk of depression, 
learn about parental concerns, provide health promotion, assist with consistent parenting, and 
offer simple behavioural changes for youth (Van Cleve et al., 2013). Primary care allows 
NPs to use preventive approaches to reduce the risk of both depression and thus comorbid 
conditions in adolescents through early intervention of depression pathogenesis and 
modification of risk factors (Van Voorhees et al., 2007). Thus, already knowing and having a 
partnership with a provider may encourage earlier diagnosis, fosters trust, and provides the 
best position for adolescents with depression to receive care. 
Several factors influenced the development of this integrative review including: 
increased severity and prevalence of adolescent depression, the need to treat depression 
appropriately despite the risk of side effects, recent advancement of depression to a moderate 
risk factor for CVD by the American Heart Association, crossover of physiological effects 
between CVD and MDD, limited research of easy and efficient tools to screen for CVD in 
adolescents with MDD in primary care, and a lack of clinical guidelines about how to 
prevent, mitigate, and treat the risk predictors of CVD in adolescents with depression.  While 
there may be many PCPs comfortable diagnosing, managing, and treating adolescents with 
depression in primary care practices, there remains aspects of these adolescents’ care that are 
not being properly addressed. This neglect of care adds to the detriment of not only the future 
health of these adolescents but also contributes to rising societal costs of both their 
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healthcare and their future function within society. The healthcare system provides many 
supports to aid PCPs in caring for adolescents with depression including: validated tools to 
screen for and diagnose depression in adolescents displaying signs and symptoms; clinical 
practice guidelines and protocols addressing the basic care, non-pharmacological 
management, and pharmacological treatment of adolescents with depression; evidence 
supporting the risks, benefits, and side effects of using fluoxetine, other SSRIs, and 
antipsychotic medication to treat adolescent depression and why treatment adolescent 
depression is more beneficial and safer than not treating it; and emerging research that 
depression in adolescents leads to long-term cardiovascular changes that put the individual at 
a higher relative risk of atherosclerotic changes, increased BMI, non-fatal MIs, and cardiac 
mortality. Additionally, there is validation that preventive health checklists provide both an 
efficient and reliable way to integrate important disease prevention and health promotion 
aspects of care into the primary care encounter, yet there are no tools available to monitor the 
cardiovascular risk to adolescents with MDD. The objective of this paper is to determine if 
preventive health checks for cardiovascular risks will help decrease future cardiovascular 
disease in adolescents with depression.  
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CHAPTER TWO 
Methods 
A literature review was carried out to determine if preventive health checks are 
effective tools for determining cardiovascular risk in adolescents with depression. The 
methodological process for reviewing the literature was completed in four stages.  
Stage One: Identification of Issue and Search Strategy 
Stage one began with identification of key terms related to the subjects of 
“adolescents”, “depression”, “preventive health check”, “cardiovascular risk predictors” and 
“improved health outcomes”. To ensure the search was conducted with all related terms, a 
concept map, thesaurus, and eMedicine Health from WebMD was used to identify synonyms 
and similar terms. Related medical terms for ‘depression’ include: clinical depression, major 
depressive disorder, dysthymia, major depression, and depressive disorder (WebMD, 2016). 
Some synonyms for adolescents include: teenagers, youth, young adults, teens, juveniles, and  
minors. Other related terms for ‘preventive health check’ include preventive screening, 
annual screening, or health screening. Associated terms for ‘cardiovascular risk predictors’ 
include: clinical risk predictors of cardiovascular mortality and cardiovascular morbidities. 
Lastly, related terms for ‘improved health outcomes’ are: improved quality of life; greater 
life expectancy; increased well-being; and decreased morbidity. The terms were further 
examined in a health-related database to determine the medical subject headings (MeSH) 
when applicable. MeSH terms for “depression”, include “depressive disorder, major” and 
“depression, physiological long term”. The MeSH terms for “preventive health check” are 
“preventive health service”, “health promotion”, “preventive health medicine”, “primary 
prevention” and “risk predictors”.  
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The databases used to conduct the literature search are those with relevance to health 
sciences, nursing, and medicine. To supply the best evidence for this integrative review, this 
literature search began at the top of the ‘6S pyramid’ with the highest quality evidence and 
searched systems, summaries, synopses of syntheses, syntheses (systematic reviews), 
synopses of studies and finally studies (Wilczynski & McKibbon, 2013). This led to searches 
of UpToDate, First Consult, ACP Journal Club, the National Guideline Clearinghouse, 
PubMed by MEDLINE, Science Direct, and Medline by OVID. An online search was 
conducted using professional and government websites such as Health Canada, Government 
of Canada, World Health Organization, and American Heart Association.  
The initial literature search was conducted in PubMed by MEDLINE, because it has 
natural language algorithms that find related keywords and subject headings, making it the 
best place to start using the following search terms: (adolescents OR youth) AND 
(depression OR major depression OR *depressive disorder) AND (improved physical health 
outcome* OR quality of life OR greater life expectancy) AND (mass screening) AND 
(cardiovascular risk predictors OR cardiovascular risk assessment OR cardiovascular risk 
management). The search implemented in Science Direct and Medline by OVID used 
different search terms to avoid duplication of articles and increase the robustness of search 
strategy. Science Direct included the terms (adolescents AND depression AND 
cardiovascular risk predictors AND preventive health checks) while the search in Medline by 
OVID included Adolescents OR youth + cardiovascular risk OR cardiovascular disease OR 
atherosclerosis + depression or major depressive disorder. The searches of UpToDate, First 
Consult, ACP Journal Club, National Guideline Clearinghouse, Health Canada, Government 
of Canada, World Health Organization, and American Heart Association were all conducted 
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using the key search terms ‘adolescents’, ‘depression’, ‘preventive health checks’, 
‘cardiovascular risk factors’, and ‘improved health outcomes’. This strategy resulted in a 
total of 67,674 articles for further evaluation. 
Stage Two: Focused Search 
The search was narrowed by applying inclusion and exclusion criteria (Table 1) 
restricting articles to those from the last ten years, those with human subjects, English 
written articles, journal articles, those with abstracts available and those articles from North 
America, Canada, United States, Australia, New Zealand, Britain, and Europe. These 
countries were chosen because they are culturally and geographically more similar to Canada 
than Asia or Africa. Additionally, because this project focuses on depression and 
cardiovascular health specifically in adolescents, articles that do not have ‘depression’, 
‘adolescents’, or ‘cardiovascular’ in the title or abstract were excluded. Finally, articles that 
did not include some focus on health promotion, health prevention or screening, or improved 
health outcomes were also excluded. This resulted in 53 total articles to be read in full. 
 Table 2 details the systematic thinning of articles through the evaluation of their 
titles, abstracts, and text until eight original journal articles meeting all of the inclusion 
criteria and displaying none of the exclusion criteria were revealed for use in this integrative 
review.  
Table 1: Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
Publication dates less than 10 
years old (2006-2016) 
Any articles that do not focus on health promotion, 
prevention, or improved outcomes 
Use of human subjects only Any article without ‘adolescents’ in title or abstract 
Written in English 
 
Any articles not based in North America, Australia, New 
Zealand, Britain, and Europe 
Journal articles only 
Full text available Any articles without ‘cardiovascular’ in title or abstract 
Title and abstract available Any articles withut ‘depression’ in title or abstract 
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Table 2: Stage Two Focused Search Results  
Database Search  Exclusion Selection based on 
Abstract/Title  
Read article  
PubMed by Medline n = 66494 Within 10 y   
n = 47992 
n = 23 n = 5 
Human 
subjects   
n = 42661 
English  
n = 40155 
Adolescents  
n = 3246 
Abstract  
n = 3180 
Journal articles  
n = 3171 
Location 
n = 1049 
Science Direct n = 912  n = 74 n = 8 n = 2 
Medline by OVID n = 11 n = 9 n = 8 n = 1 
UpToDate n = 37 n/a n = 3 n = 0 
First Consult n = 39 n/a n = 4 n = 0 
ACP Journal Club n = 42 n/a n = 0 n = 0 
National Guideline 
Clearinghouse 
n = 19 n/a n = 0 n = 0 
Health Canada n = 5 n/a n = 0 n = 0 
Government of 
Canada 
n = 18 n/a n = 4 n = 0 
WHO n = 54 n/a n = 0 n = 0 
American Heart 
Association 
n = 18 n/a n = 3 n = 0 
Total 67,674 1132 53 8 
 
Stage Three: Study Quality Analysis 
 Stage three involved a detailed analysis of the chosen articles for quality of evidence . 
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) Model was used to 
determine the quality of the eight articles. This model rates the strength of the evidence 
based on: 1) the type of study; 2) the strength of the study design including sample size, 
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whether participants are randomized, if there is a control group, whether the groups are 
treated equally, if the data collection methods are clearly described; 3) the study results 
including whether the results are clearly presented and analyzed properly; and 4) the study 
conclusions were based on clearly presented results and that the limitations are identified and 
discussed (The Johns Hopkins Hospital & The Johns Hopkins University, n.d.).  
In the JHNEBP Model evidence is rated as level I for experimental studies such as 
randomized controlled trials; level II for quasi-experimental studies; and level III for non-
experimental studies and qualitative reviews (The Johns Hopkins Hospital & The Johns 
Hopkins University, n.d.). Quality of the research is rated as follows: high or ‘A’ for research 
with consistent, generalizable results that have sufficient sample sizes, adequate internal and 
external control, and clear recommendations based on scientific results; good or ‘B’ for  
reasonably consistent results, sufficient sample size, some internal and external control, and 
fairly definitive conclusions based on fairly comprehensive literature review; and finally 
low/major flaws or ‘C’ for little evidence with inconsistent results, insufficient sample size, 
and unable to draw any conclusions (The Johns Hopkins Hospital & The Johns Hopkins 
University, n.d.).  
The articles chosen for this integrative review included one meta-analysis, one quasi-
experimental, and six non-experimental studies, consisting of three longitudinal follow-up 
studies and three cohort studies. The level and quality of the evidence for the research 
articles used in this review are: ‘high’ for the meta-analysis and ‘good’ for the other seven 
study articles as seen in Table 3.  
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Table 3: Evidence Rating for Research 
Author/Date Title of Article Type of Article Level of 
Evidence 
Grade of 
Article 
Dietz & 
Matthews 
(2010) 
Depressive symptoms and 
subclinical markers of 
cardiovascular disease in 
adolescents 
Cohort study  
Non-
experimental 
III B – good 
Flores et al. 
(2015)  
Perceived health status and 
cardiometabolic risk among a 
sample of youth in Mexico 
Exploratory 
cohort study 
Non-
experimental 
III B – good 
Goldstein et 
al. (2015) 
Major depressive disorder and 
bipolar disorder predispose 
youth to accelerated 
atherosclerosis and early 
cardiovascular disease 
Systematic 
review with 
meta-analysis of 
quasi-
experimental 
studies 
II A – high 
Louise et al. 
(2012) 
Associations between 
anxious-depressed symptoms 
and cardiovascular risk 
factors in a childhood study 
Longitudinal 
Non-
experimental 
 
III B – good 
 
Meier et al. 
(2015) 
Associations between 
depression and anxiety 
symptoms with retinal vessel 
caliber in adolescents and 
young adults 
Longitudinal 
Non-
experimental  
III B – good 
 
Rottenberg et 
al. (2014) 
The association between 
major depressive disorder in 
childhood and risk factors for 
cardiovascular disease in 
adolescence 
Cohort study 
Non-
experimental 
III B – good 
 
Shah et al. 
(2011) 
Depression and history of 
attempted suicide as risk 
factors for heart disease 
mortality in young individuals 
Longitudinal 
study 
Non-
experimental 
III B – good 
 
Waloszek et 
al. (2015a) 
Early physiological markers 
of cardiovascular risk in 
community based adolescents 
with a depressive disorder 
Cohort study 
Quasi-
experimental 
 
II B - good 
 Stage Four: Identification of Key Themes 
Stage four involved a detailed thematic evaluation of these eight studies to identify 
key themes in relation to the research question. Themes identified in the literature included: 
gender differences in the expression of cardiovascular risk and depression; comparison of 
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clinical or self-reported diagnosis of depression in relation to cardiovascular risk; 
pathophysiological changes of depression; and measures of traditional clinical cardiovascular 
risk predictors in adolescents with depression. The findings section will provide a critical 
analysis of the quality of evidence presented in each research paper.  
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CHAPTER THREE 
Findings 
The following section will provide a critical analysis of the research findings, 
organized by key themes, with consideration of what is missing from the current findings, 
and indication of the relevant limitations and/or biases of each study. The themes identified 
include: gender differences in the expression of cardiovascular risk and depression; 
comparison of clinical or self-reported diagnosis of depression in relation to cardiovascular 
risk; pathophysiological changes of depression; and measures of traditional clinical 
cardiovascular risk predictors in adolescents with depression. The quality of the articles was 
evaluated based on the JHNEBP Research Evidence Appraisal tool. Of the eight studies 
included for use in this integrative review, one is of high quality or rated ‘A’, while the other 
seven are of good quality or rated ‘B’. Thus, the methodological quality of the research 
studies is acknowledged to have flaws, which will be addressed, discussed, and analyzed 
further throughout this integrative review. 
Gender Differences in the Expression of Cardiovascular Risk and Depression 
When determining whether the use of preventive health checks would improve 
cardiovascular co-morbidities in adolescents living with depression, it is important to 
identify whether gender is consistently identified as a risk factor. Many risk prediction 
algorithms and equations, including those for cardiovascular events such as the FRE as well 
as those predicting episodes of major depression, account for gender when estimating the 
probability of onset or risk of a specific disease or illness (D’Agostino et al., 2008; King et 
al., 2008). Gender as an independent patient characteristic is often used to distinguish the 
difference in risk of not only current health status but the future health of males and females. 
Traditionally, atherosclerosis developed later in life for females than males, likely due to the 
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protective nature of estrogen, making it imperative to determine if gender disproportionately 
affects both the risk of depression or CVD differently (Elovainio et al., 2005), in order to 
provide necessary screening at the appropriate time in life. Older studies have shown that a 
high level of depressive symptoms is associated with increased cardiovascular risk in young 
men only (Elovainio et al., 2005); however, more current literature was evaluated and found 
that gender differences still exist in the expression of depression and cardiovascular risk, 
though the higher risk is now inferred in females. Thus, gender is an integral component of 
health and must be a key focus of preventive health checks as it assists PCPs to easily and 
efficiently identify which patient is most at risk for certain health conditions and who would 
benefit the most from screening or assessments within primary care.  
Three of the eight studies showed differences of gender in the expression of 
depression and cardiovascular risk. Two studies showed gender differences in the clinical 
measurement of vital signs. Adolescent males had both higher brachial and continuous beat-
to-beat finger systolic blood pressures and heart rates as well as a lower rate of change for 
systolic blood pressure than adolescent females (Louise et al., 2012; Waloszek et al., 2015a). 
Blood pressure measurement in depressed boys compared to girls who are depressed was 
113.8 mmHg versus 108.9 mmHg respectively (Louise et al., 2012). Gender accounts for 
many differences of health between men and women including: physical alterations with the 
amount of muscle mass, distribution of fat, and measurements of height, weight, hips, and 
waist; variances in the sex hormones of estrogen, testosterone, and progesterone, and how 
these hormones affect the metabolism and use of other substances including lipids, fatty 
acids, leptin, catecholamine, insulin, glucose, epinephrine, and nitric oxide; and physiologic 
modifications to the circulating blood volume, amount of free fluid, and amount of 
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hemoglobin (Wu & O’Sullivan, 2011). While blood pressure and heart rate are both easily 
obtainable and measurable signs of health, their elevation or lowered rate of change is not 
sufficient to solely predict future cardiovascular co-morbidity in adolescents with depression 
because many factors including infections, stress, dehydration, and anemia can elevate heart 
rate or blood pressure. However, subtle changes of heart rate and blood pressure measured 
over a period of time coupled with the well-known gender differences in weight, hormones, 
and metabolism can provide better, clearer information about the overall function, stress, and 
severity of damage or inflammation to the cardiovascular system. These specific vital signs 
along with gender are used to predict adult CVD in the FRE and thus may predict significant 
CVD when used in adolescents with depression. Thus, blood pressure and heart rate are 
important measurements of cardiovascular function, but not in absence of other factors.  
In addition, Louise et al. (2012) found that depressive symptoms in girls were 
associated with a higher BMI (0.6 kg/m2) and a higher insulin resistance (0.3 units) than in 
girls without depressive symptoms. While BMI is another easily obtainable and measurable 
sign of general health, its elevation is not a clinically useful determinant of altered 
cardiovascular health. However, elevated BMI and insulin resistance are two risk factors in 
the diagnosis of metabolic syndrome, the most predictive risk factor of CVD. Metabolic 
syndrome is defined as a cluster of interconnected factors including elevated blood pressure, 
dyslipidemia, dysregulated glucose homeostasis, increased adiposity, and insulin resistance, 
moreover the prevalence of metabolic syndrome increases dramatically as BMI increases 
(Kassi, Pervanidou, Kaltsas, & Chrousos, 2011). In fact, Kassi et al. (2011) found that an 
elevated BMI considered overweight increased the risk of metabolic syndrome five and a 
half times in adult females and six times in adult males compared to normal or underweight 
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patients, while an elevated BMI in the obese range increased the risk 32 times in adult males 
and 17 times in adult females.  
The third study showed that young women with both depression and previous 
attempts at suicide were at higher risk for both CVD and ischemic heart disease mortality but 
not for non-CVD mortality, whereas the opposite was true for young men (Shah, Veledar, 
Hong, Bremner, & Vaccarino, 2011). In fact, the hazard ratio for ischemic heart disease 
mortality in young women with depression and attempted suicide was 14.57 compared to that 
of young men which was 3.52, while the hazard ratio for CVD mortality in young women 
was 3.20 compared to 2.37 in young men (Shah et al., 2011). Furthermore, when adolescents 
who were taking antidepressants were excluded from data analysis, the hazard ratio of 
ischemic heart disease for depression was changed by less than 10%, indicating that the 
cardiovascular risk of depression remains even after it has been treated (Shah et al., 2011).  
There are some limitations in these studies that may affect the validity of their results. 
Two of the studies had relatively small sample sizes, one with very few male participants, 
which both limits the power of statistical analysis and causes wide confidence intervals 
(Shah et al., 2011; Waloszek et al., 2015a). This made it difficult to conclude what effects, if 
any, gender had on both depression and cardiovascular risk as many of the gender interaction 
results were not statistically significant (Shah et al., 2011; Waloszek et al., 2015a). Waloszek 
et al. (2015a) determined that gender imbalances are expected in depression studies given the 
epidemiological differences of depression in women and that depression is more prevalent 
and presents earlier in women than in men, as well as the fact that women are more likely 
then men to seek care for depression, both of which may help explain some of the gender 
differences presented in the studies.  
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Thus, in determining whether gender affects cardiovascular risk in adolescents with 
depression, it appears that either gender contributes to physiological changes that may 
contribute eventually to CVD. For adolescent males, these changes include increased blood 
pressure and lower heart rate variability. Yet, for adolescent girls, more significant variances 
were found including increased BMI, increased insulin resistance leading to an increased risk 
of metabolic syndrome, as well as a marked risk of mortality from ischemic heart disease. 
Therefore, being female may be not only a contributing risk factor to cardiovascular 
morbidity, but also an equally important predictor in the determination of CVD. Therefore, it 
is advisable to include gender in a preventive health checklist when assessing for 
cardiovascular co-morbidity as being female not only significantly increases individual risk 
of CVD but its identification may help prevent future morbidity and mortality in adolescents 
with depression.  
Diagnosis of Clinical or Self-Reported Depression in Relation to Cardiovascular Risk 
 Half of the studies examined for this integrative review described how the diagnosis 
of depression was determined. Participants were identified as having depression in one of 
two ways. First, some individuals’ depression was determined based on self-reported 
questionnaires that were completed by the individual, while other studies used clinical 
experts to administer a clinical tool. These two ways of diagnosing depression have many 
different implications not only for the research studies and their outcomes, but for future 
integration into practice as well. When determining whether preventive health checks would 
improve later cardiovascular co-morbidities in adolescents with depression, it is important to 
define which adolescents with depression are most at risk, the ones that have been clinically 
diagnosed, or the ones that have self-reported depressive symptoms. It is only just recently 
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that major depressive disorder has been considered a moderate risk factor for CVD, which 
may imply that a clinical diagnosis of depression has to be present to infer cardiovascular 
risk (de Ferranti & Newburger, 2016a). Currently, MDD is not part of the FRE, however, 
there have been a few studies in adults suggesting its addition to the risk equation (O’Neill et 
al., 2016b). Conversely, it is important to understand whether having subclinical, self-
reported, or perceived depression can affect adolescents’ cardiovascular risk and lead to 
future co-morbidities. This is important not only for NPs to understand in order to effectively 
care for and appropriately manage and prevent cardiovascular co-morbidities, but is also 
important when allocating difficult to access resources such as mental health professionals. If 
adolescents require a diagnosis of MDD from a clinical expert this further taxes an already 
burdened system and may take a significant amount of time before reaching a diagnosis, 
perhaps delaying management of cardiovascular risk. However, if having depression by self-
reported questionnaire infers a similar level of risk for CVD, primary care providers can 
assess risk for any adolescents based solely on depressive symptoms and use an appropriate 
preventive health checklist to stratify risk and determine who warrants management, 
treatment, and care of CVD sooner, in order to more effectively and efficiently reduce the 
risk of future co-morbidities. 
 Three studies used self-reported questionnaires to identify depressive symptoms in 
adolescents. In each of the studies a different type of questionnaire tool was used to screen 
for depression, including the Children’s Depression Inventory: Short Version (CDI-S) 
(Flores et al., 2015); the Center for Epidemiologic Studies Depression Scale (CES-D) (Dietz 
& Matthews, 2011); and the Somatic and Psychological Health Report (SPHERE) (Meier et 
al., 2015). The only tool that has been identified as a recommended screening tool for 
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assessing depression by the CPS (2016) is the Child Depression Inventory 2 (CDI-2), a tool 
very similar to the CDI-S. Flores et al. (2015) report that the CDI is widely used in many 
countries and has been shown to be both valid and reliable for measuring depression in 
youth. In their study, Flores et al. (2015) dichotomized the adolescents into two groups based 
on their depressive scores, either less than average or average depressive symptoms, and 
greater than average depressive symptoms. The researchers then compared these levels of 
depressive symptoms to cardiometabolic measures by BMI status. Statistical significance 
was reported between the relationship of increased BMI and increased depressive symptoms, 
worse physical functioning, and lower quality of life scores (Flores et al., 2015). Another 
statistically significant trend was recognized between participants who were either 
‘overweight’ or ‘obese’ and had both higher glucose and triglyceride blood levels as well as 
higher systolic and diastolic blood pressure readings (Flores et al., 2015). Moreover, what 
these findings suggest is that there is a correlation between self-reported depressive 
symptoms using a validated and reliable tool and the presence of cardiovascular  risk factors 
such as increased BMI, increased glucose and triglyceride levels, and increased systolic and 
diastolic blood pressure.   
Meanwhile, the CES-D “has been used in a variety of settings and has shown 
construct validity in its ability to screen for the presence of depressive disorders” (Dietz & 
Matthews, 2011, p.580). In their study, Dietz and Matthews (2011) also divided the 
participants into three separate groups reflecting depressive severity based on the range of 
scores. These scores were: 0-7 or low, 8-14 or moderate, and 15-47 or high, which correlated 
closely with the clinical use of the CES-D, whereby scores greater than 16 generally 
“indicate the presence of clinically significant depressive symptoms” (Dietz & Matthews, 
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2011, p.580). So, while Dietz and Matthews make no mention of the reliability of this tool to 
produce consistent scores of depressive symptoms, they do conclude that their scores of high 
depressive symptoms and clinically significant depressive symptoms closely correspond to 
each other. Adolescents with the highest score of depressive symptoms were found to have 
statistically significant relationships with higher pulse wave velocity (PWV) or more arterial 
stiffness, even after adjusting for age, race, gender, BMI, smoking status, socioeconomic 
status, physical activity, blood pressure, and heart rate (Dietz & Matthews, 2011).  
Limitations of this study may include the fact that the authors do not mention whether this 
tool is appropriate for assessing depression in adolescents, and that the depressive symptoms 
and PWV were measured at a single point in time only, making it difficult to infer a 
relationship over a period of time.  
Finally, the study by Meier et al. (2015) used the SPHERE self-report questionnaire, 
which assesses symptoms of depression, anxiety, and somatic distress and yields a total score 
for not only overall mental health and well-being but also for affective symptoms of 
depression, somatization, and fatigue. The authors reported that SPHERE has adequate 
reliability, validity, and internal consistency, as well as accurate identification of over 90 
percent of individuals with current diagnosable depression, anxiety, or somatoform disorders 
(Meier et al., 2015). Further, the study found that there is a correlation between higher self-
reported rates of symptoms from depression/anxiety, somatization, and fatigue, with poorer 
overall mental health and well-being (Meier et al., 2015). In fact, the study found that 
adolescents with higher reports of depressive symptoms had statistically significant 
associations with wider retinal arteriolar caliber, a sign of impaired autoregulation and 
microvascular abnormality that predicts future risk of CVD, even after the authors controlled 
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for smoking and BMI (Meier et al., 2015). Moreover, while the symptoms for somatization, 
fatigue, and overall mental health also showed a trend toward widening of arteriolar caliber, 
the effects did not reach statistical significance (Meier et al., 2015).  
However, this study also has several limitations, including that the authors did not 
mention if the SPHERE questionnaire is validated or reliable for use in adolescents, nor does 
it specifically distinguish between depression and anxiety symptoms, making it unclear as to 
whether wider retinal arteriolar caliber is differentially associated with depression or anxiety. 
Another limitation is that the self-reported questionnaire and the retinal arteriolar caliber 
were not measured concurrently, in fact for most participants there was a mean time lapse of  
two and a half years between assessments which may have weakened the significance of the 
association. The authors make note of this limitation in their discussion and consequently 
performed a sub-analysis of those participants that had both depression/anxiety data and their 
retinal arteriolar caliber assessed within one year of each other for which the results 
remained statistically significant (Meier et al., 2015). A third limitation is that both retinal 
vessel caliber and the self-reported questionnaire were each only taken at a single point in 
time, making the direction of the association between these two items unclear, perhaps 
limiting their significance to practice. Thus, while this study shows a statistically significant 
association between depression/anxiety and wider retinal arteriolar caliber, a marker of 
endothelial dysfunction and a known risk factor for future CVD, the limitations of using a 
tool that is not specific to adolescents nor depression make it difficult to conclude whether 
these self-reported symptoms of depression do, in fact, correspond to an elevated expression 
of cardiovascular risk.  
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One study examined the association between CVD and depression using a clinical 
diagnosis of unipolar depression measured by the Diagnostic Interview Schedule (DIS), a 
standardized, structured interview tool based on the DSM-III criteria (Shah et al., 2011). The 
DSM is an authoritative guide to the accurate, consistent, and standardized diagnosis  or 
classification of mental health disorders used by health care professionals around the world 
(American Psychiatric Association, 2013). Further, the DIS is a fully structured 
questionnaire administered by trained interviewers, not necessarily clinicians, to ascertain the 
existence or absence of mental health disorders based on the DSM (University of Florida 
Health, 2017). This tool mimics a clinical interview to determine whether psychiatric 
symptoms are clinically significant and whether or not they can be attributed to a medical 
condition or substance use (University of Florida Health, 2017). As the DIS is a fully 
specified tool, it remains valid and reliable even when non-clinicians administer it 
(University of Florida Health, 2017).  
This study by Shah et al. (2011), in which the DIS was implemented for diagnosis of 
depression, was conducted with a large sample of 7968 young adults aged 17-39. The results 
showed that depression is related to all-cause CVD mortality; 51 participants died from 
cardiovascular-related deaths, including six people with depression and four that had 
attempted suicide. This can be stated in terms of a hazard ratio of 2.38 for CVD mortality in 
people with depression after adjusting for age, gender, and ethnicity, and a hazard ratio of 
2.21 after adjusting for traditional risk factors (Shah et al., 2011). Additionally, ischemic 
heart disease (IHD) mortality also had significant associations with depression. Over the 
fifteen years of follow-up, there were 251 total deaths, 15 from suicide and 51 from CVD 
(Shah et al., 2011). Of the 28 people who died from IHD, five had depression, making the 
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hazard ratio almost four times higher for people with depression, even after adjusting for 
gender, race, and traditional risk factors (Shah et al., 2011). More importantly, when the 
authors controlled for subjects taking antidepressant therapy, the hazard ratio of IHD was 
changed by less than ten percent. This study suggests that to mitigate the cardiovascular risk 
associated with depression, PCPs need to do more than simply treat adolescents’ underlying 
depression. Once can infer that to prevent future CVD mortality in young patients with 
depression, their risk must be predicted and managed early using a preventive approach to 
reduce stress, eat a healthy diet, and be more physically active. 
Important limitations to note with this study are the limited power of analysis (10% 
instead of the usual 5%) and wide confidence intervals related to the low number of cardiac 
events in younger participants, perhaps contributing to bias (Shah et al., 2011). However, the 
authors acknowledge that while the limited power of analysis made it difficult to draw 
definite conclusions about CV risk related to gender differences, reducing the ratio of 
outcomes to risk factors increased the accuracy of the relative risk estimation (Shah et al., 
2011). Shah et al. (2011) reduced the ratio of risk factors to outcomes by combining all of the 
risk factors and using the FRE to convey overall CVD risk rather than individual CVD risk 
factors. Additionally, the authors performed a series of sensitivity analyses between the risk 
factors and outcomes, under which the results remained robust, lending to the validity of the 
entire study (Shah et al., 2011).   
In conclusion, three studies used self-reported, subclinical, or perceived symptoms of 
depression while one study used a clinical diagnosis of depression to evaluate the 
associations with cardiovascular risk. All four of the studies found statistically significant 
associations between the symptoms of depression and various physiological changes that 
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could infer future cardiovascular risk, including wider retinal arteriolar caliber, increased 
PWV, and increased traditional risk factors. The study using a clinical diagnosis of 
depression by Shah et al. (2011) also found an increased mortality from cardiovascular 
causes in depressed individuals than in individuals without depression. While these 
associations were all significant, none of the studies, with the exception of the study by Shah 
et al. (2011), examined cardiovascular changes over time, making it difficult to know 
whether these physiological changes represent an incidental variation or whether they 
represent a gradual or permanent physiological dysfunction that may eventually contribute to 
end cardiovascular damage. However, when determining whether self-report or a clinical 
diagnosis of depression makes a difference to predicting the risk of CVD, it appears as 
though both confer risk. Therefore, preventive health checklists should include assessment of 
depressive symptoms as a stimulus to screen for CVD risk factors.  
Pathophysiological Changes of Depression  
 Half of the studies examined for this integrative review described pathophysiological 
changes of CVD in adolescent depression. This section will examine the four studies that 
found both autonomic and endothelial dysfunction, including changes such as heart rate 
variability, shorter pulse transit time, wider retinal arteriolar caliber, and brachial artery 
dilation (Dietz & Matthews, 2010; Goldstein et al., 2015; Meier et al., 2015; Walsozek et al., 
2015). Early identification and management of these pathophysiological and endothelium 
changes may potentially reverse damage and reinstate function. However, this early 
identification requires knowledge of the problem and a systematic way in which to screen for 
these potential problems in adolescents with depression. This may best be done using a 
preventive health check, which is able to accurately guide the PCP to those patients most at 
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risk of these pathophysiological changes and therefore those most at risk of developing 
cardiovascular disease. 
 Arterial stiffness. Three studies chose to look at different measurements of arterial 
stiffness in adolescents as a pathophysiological sign of cardiovascular dysfunction. Arterial 
stiffness represents a decrease in the intrinsic elasticity of the vessel wall, usually caused by 
calcification of atherosclerotic plaques (Cecelja & Chowienczyk, 2012). This stiffness 
reduces the artery’s ability to respond to pressure changes, often causing hypertens ion and 
increasing the workload of the heart, which may over time lead to cardiac morbidity and 
mortality (Cecelja & Chowienczyk, 2012). Arterial stiffness can be measured by any of the 
following: increased carotid artery intima-media thickness (CIMT); faster pulse wave 
velocity time (PWV); or shorter pulse transit times (PTT) (Cecelja & Chowienczyk, 2012; 
Dietz & Matthews, 2011; Goldstein et al., 2015; Waloszek et al., 2015a). In fact, PWV that is 
measured over the aorta of the heart has been found to be an independent predictor of 
cardiovascular morbidity and mortality, while an increase in intima-media thickness 
represents atherosclerosis (Cecelja & Chowienczyk, 2012).  
One prospective cohort study and a meta-analysis reviewed CIMT as a risk predictor 
of CVD in adolescents with depression. Both found that there was no correlation between 
these variables (Dietz & Matthews, 2011; Goldstein et al., 2015). Dietz and Matthews (2011) 
report that adult studies have shown a correlation between increased CIMT and depression, 
suggesting that increased CIMT may be an advanced sign of cardiovascular dysfunction that 
is better correlated to age than disease process. There are a few important limitations in these 
studies by Dietz & Matthews (2011) and Goldstein et al. (2015) including: the relatively 
small sample size (157 participants) of one study (Dietz & Matthews, 2011), which may not 
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represent enough of the population to draw accurate conclusions; and the fact that another 
study is not considered current as it was published in 2005 and measured the CIMT of 
participants in 2001, perhaps using older technology that is not as accurate in measuring 
CIMT as ultrasound machines are today (Elovainio et al., 2005). Finally, both studies 
determined the relationship between arterial thickening and depression by self-reported 
depressive symptoms, which may not accurately depict adolescents who experience more 
chronic or severe depression that may contribute to poorer health behaviours such as 
increased time doing sedentary activities or greater disruption of circadian sleep cycles 
(Dietz & Matthews, 2011; Elovainio et al., 2005; Goldstein et al., 2015). 
However, an earlier and perhaps a more accurate predictor of cardiovascular 
dysfunction in adolescents is PWV, a sign of increased vascular stiffness that can be found 
even when there is a low prevalence of atherosclerosis (Cecelja & Chowienczyk, 2012). 
PWV measures arterial stiffness based on the principle that pressure waves travelling from 
the aorta to a predetermined end-point are faster if the arterial vessel walls are stiffer (Dietz 
& Matthews, 2011). Waloszek et al. (2015a) measured the pulse transit time (PTT) in their 
study, which measures arterial stiffness from the R-wave to the following diastolic pressure 
point, also noting that the transit time is shorter in stiffer vessels due to the decreased 
resistance of the vessel walls, thus allowing blood to travel faster from the heart to the 
periphery (Waloszek et al., 2015a). Both the studies by Dietz and Matthews (2011) as well as 
by Waloszek and colleagues (2015a) found significant associations between stiffer vessels 
and depressive symptoms in adolescents. Dietz and Matthews (2011) found a significant 
relationship between PWV and depressive symptoms in adolescents even after adjusting for 
age, race, gender, BMI, education level of parents, smoking status, physical activity, blood 
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pressure, and heart rate. In fact, the more severe the depression, the higher the PWV. In the 
study by Waloszek et al. (2015a) adolescents with depression also had significantly shorter 
PTT when compared with their non-depressed cohorts. Both of these studies suggest that 
there are early vascular changes of CVD associated with depression in adolescents; however, 
both studies had relatively small sample sizes that may have limited the validity of the 
findings. 
Endothelial dysfunction. Another early sign of CVD is impaired endothelial 
function, a loss of the integrity and then dysfunction of the blood vessel wall often due to the 
chronic exposure of noxious stimuli such as stress that eventually overwhelms the body’s 
defense mechanisms (Mudau, Genis, Lochner, & Strijdom, 2012). This process is thought to 
be the pathophysiological link between exposure to cardiovascular risk factors, including 
depression, and atherosclerosis (Mudau et al., 2012). Waloszek and colleagues (2015a) 
measured endothelial functioning in adolescents with depression using an EndoPAT 
machine, a non-invasive finger plethysmography, which captures the arterial vasodilation of 
a finger from each hand at rest and after shear stress (a five-minute cuff occlusion of the 
brachial artery in one arm to induce vasodilatory molecules). The EndoPAT has been found 
to be both reliable and valid in capturing nitric-oxide mediated vasodilation and finger 
endothelial function in both pediatric and adolescent populations (Tomfohr, Murphy, Miller, 
& Puterman, 2011; Waloszek et al., 2015a). Waloszek et al. (2015a) found that adolescents 
with depression had poorer endothelial functioning when compared with their healthy peers, 
indicative of increased cardiovascular risk and future atherosclerosis.  
Goldstein et al. (2015) reviewed five studies that measured endothelial function by 
either “ultrasound-determined brachial artery flow-mediated dilation or by digital pulse-wave 
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amplitude, in which higher values are considered better” (p. 968).  Of the five studies from 
this meta-analysis, one showed no relationship between endothelial dysfunction and 
depression in adolescents, while the other four, similar to Waloszek et al. (2015a), showed 
some change in endothelial dysfunction in adolescents with depression. Of the studies that 
showed an association between endothelial dysfunction and depression in adolescents, one 
study found this not to be significantly present over time nor to predict future endothelial 
function; one showed attenuated endothelial function only in adolescent girls with higher 
levels of anger, depression and anxiety; one showed decreased nitrite concentrations in 
depressed adolescents suggesting decreased nitric oxide production, a sign of endothelial 
dysfunction; and the last study demonstrated a smaller brachial artery diameter in 
participants with depression, which is indicative of stiffer vessels (Goldstein et al., 2015; 
Osika et al., 2009; Tomfohr et al., 2011; Waloszek et al., 2015a).  
Both the meta-analysis by Goldstein et al. (2015) and the cross-sectional study by 
Waloszek et al. (2015a) admitted that it is difficult to conclusively form a relationship 
between depression in adolescents and future cardiovascular risk as most of the study sample 
sizes were small and had insufficient power to be statistically significant. However, five 
smaller studies have been presented equalling a total number of 563 participants, showing 
that there is likely some level of endothelial dysfunction in adolescents with depressive 
symptoms. What that association is specifically has yet to be determined. Some of the studies 
in the meta-analysis suggested the relationships between endothelial dysfunction and 
adolescent depression were significant only in females, while other studies concluded that 
depressive symptoms that were self-reported were less significant than when MDD was 
diagnosed from the use of semi-structured interviews (Goldstein et al., 2015). Whether or not 
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this association would be stronger in a study with a larger sample sizes, one thing is certain; 
more longitudinal research is needed to investigate endothelial dysfunction as it relates to 
adolescents with depression. Further, more information is needed on whether the EndoPAT 
would be a valuable and reliable non-invasive method of identifying adolescents with 
depression at risk of cardiovascular disease in primary care.  
Microcirculation changes. A well documented marker of premature subclinical CVD 
is deviation to either wider or narrower calibers of small blood vessels (Meier et al., 2015). 
This can be measured more specifically in the microcirculation of the retina, as it shares 
anatomical and physiological characteristics with other end organs such as the heart and 
kidneys that may indicated early microvascular abnormality (Meier et al., 2015). Moreover, 
changes to the retinal vessel caliber has been shown to predict future risk of CVD, and in 
adults this change to the vessel caliber has been associated with depression (Meier et al., 
2015). The authors speculate that while the direct pathophysiological mechanism of changes 
to the microvasculature is not clear, it is thought that endothelial dysfunction is caused by 
damage to the nitric oxide-mediated vasodilation of the vessels, causing them to become 
wider, a sign of impaired autoregulation (Meier et al., 2015).  
In the study of adolescents by Meier et al. (2015) the six largest arterioles and venules 
closest to the optic disc were measured to assess the average diameter of both types of 
vessels. The researchers found that symptoms of anxiety, depression, and poorer overall 
mental health were positively associated with wider arteriolar caliber (Meier et al., 2015).  
Additionally, these findings were unchanged after controlling for blood pressure, smoking 
status, and BMI (Meier et al., 2015). This large population study had its limitations, 
including that it only measured retinal vessel caliber at a single point in time and thus cannot 
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distinguish whether depression and anxiety cause wider vessel caliber, or wider arteriolar 
caliber contributes to anxiety and depression (Meier et al., 2015). Furthermore, the study did 
not measure retinal vessels at the same time as the adolescents self-reported their depression 
and anxiety symptoms, perhaps weakening the association (Meier et al., 2015). As discussed 
earlier, a sub-analysis of 345 study participants who had their retinal vessel caliber measured 
within one year of self-reporting their depressive symptoms continued to reveal a statistically 
significant association between wider retinal arteriolar vessel caliber and depressive 
symptoms (Meier et al., 2015).  
When determining whether preventive health checks would improve later 
cardiovascular comorbidities in adolescents with depression, one needs to understand the 
physiological changes inherent in CVD and whether these changes can be found in 
adolescents. The relationship between cardiovascular health and depression has been 
established in adults, yet until recently, health care professionals were unsure of whether this 
link exists in adolescence as well. The studies presented have shown three different 
indicators of cardiovascular health found in adolescents with varying levels of depression, 
including arterial stiffness, endothelial dysfunction, and microcirculation changes. These 
physiological variations in adults have been found to be predictors of cardiovascular  disease, 
and while the studies presented have their limitations mostly related to sample sizes, they 
have also suggested that early physiological changes may occur in adolescents with 
depression. Given this evidence, PCPs need to focus on how to best identify these variations 
within primary care, which risk factors contribute to the manifestation of these physiological 
changes, and how they can help the adolescent prevent CVD from ever taking place. Thus, 
using preventive health checks that support the identification of risk and need for 
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intervention may improve the health of adolescents with depression and potentially reduce 
their risk of future CVD. 
Measures of Traditional Clinical Cardiovascular Risk Predictors 
 Physiologic changes within the body can be difficult for PCPs to either identify or 
measure easily, thus there is a need to understand if any traditional clinical cardiovascular 
changes can be more easily observed and measured, and whether their use can help predict 
and thus prevent future CVD. Six of the eight studies in this integrative review examined 
clinical measures of cardiovascular risk factors including BMI, waist circumference, blood 
pressure, family history, and bloodwork such as increased cholesterol,  triglycerides, fasting 
blood glucose, and insulin levels. The clinical measures of cardiovascular risk factors will be 
divided into: 1) physical measurements and family history; and 2) blood analysis.  
 Physical measurements and family history. Five of the six studies found an 
association between depressive symptoms or MDD in adolescents and increased BMI 
(indicating obesity), increased waist circumference, or increased abdominal fat (Flores et al., 
2015; Goldstein et al., 2015; Louise et al., 2012; Rottenberg et al., 2014; Shah et al., 2011). 
Bauer et al. (2014) recognize cardio-metabolic risk as being positively correlated with an 
increased BMI and that using BMI as a physical measurement of cardio-metabolic risk is 
only predictive when identified alongside elevated insulin or those with three or more other 
cardiovascular risk factors (i.e. increased fasting glucose, increased blood pressure, increased 
total cholesterol or triglycerides). Thus, increased BMI measurement in an adolescent who is 
depressed as a lone predictive factor of CVD, may not be enough to determine risk. 
Additionally, only one study measured and found a correlation between depression in 
adolescents, increased CVD risk factors, and a family history of CVD (Rottenberg et al., 
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2014). Yet, the predictive value of family history of cardiovascular dysfunction has been 
widely used in screening measures including the FRE, which recognizes that a strong family 
history of premature CVD increases an individuals’ own risk of having early heart disease 
(D’Agostino et al., 2007). Two studies examined whether increased blood pressure, a 
common indicator of cardiac dysfunction, was related to adolescents with depression. Louise 
et al. (2012) found that males with depression had lower rate of variability in systolic blood 
pressure, while Waloszek et al. (2015a) found that in adolescents with depression both the 
mean systolic and diastolic blood pressures were higher than in the control group, however, 
the differences did not reach statistical significance.  
Overall the limitations for these studies include relatively small sample sizes, 
decreased strength of associations due to attrition of participants, and study designs that 
make it difficult to allow for the causal direction of relationships between variables to be 
made (Flores et al., 2015; Goldstein et al., 2015; Louise et al., 2012; Rottenberg et al., 2014; 
Shah et al., 2011; Waloszek et al., 2015a). However, given how many of the research studies 
found that obesity is associated with depression in adolescents, and the previous strong 
predictive value of family history as a risk factor for CVD in adults, screening for 
cardiovascular risk should focus on these two clinical markers in depressed adolescents until 
more evidence about the usefulness of blood pressure and heart rate can be found. 
Blood analysis. Four of the six studies demonstrated a relationship between 
adolescents with depression and either increased fasting blood glucose or insulin resistance 
(Flores et al., 2015; Goldstein et al., 2015; Louise et al., 2012; Waloszek et al., 2015a). 
Increased fasting blood glucose causes microvascular changes, thus making it a risk factor 
for cardiovascular disease (Canadian Diabetes Association [CDA], 2013). Moreover, two 
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studies found adolescents with depression had increased levels of triglycerides with no 
changes to HDL, LDL, or total cholesterol, and one of those studies found increased 
triglycerides to be statistically significant in males with depressive symptoms only (Louise et 
al., 2012; Waloszek et al., 2015a). The correlation between impaired fasting glucose levels, 
insulin resistance, and increased triglycerides is thought to be due to metabolic syndrome, a 
clustering of clinical and physiological variables that can lead to CVD (Goldstein et al., 
2015). The CDA (2013) defines metabolic syndrome as a syndrome of at least three of the 
following abnormalities: increased waist circumference, blood pressure greater than 130/85, 
increased fasting blood glucose, elevated triglycerides, and reduced HDL, all of which carry 
significant risk of CVD. The International Diabetes Federation (2015) outlines the criteria for 
metabolic syndrome in adolescents aged 16 and older the same as for adults, while children 
aged 10-15 need to have obesity greater than the 90th percentile as assessed by waist 
circumference and all of the four other abnormalities to be diagnosed. Goldstein et al. (2015) 
recognize that there is an increased prevalence among adults with MDD and metabolic 
syndrome. However, what is not as well understood is whether there is a correlation between 
adolescent depression and metabolic syndrome and if the same risk of cardiovascular 
morbidity and mortality is conferred from metabolic syndrome in adolescent depression, 
although Flores et al. (2015) found an association between depression and increased BMI, 
waist circumference, fasting glucose levels and lower levels of HDL cholesterol  in 
adolescents.  
Traditional risk factors of CVD that are increased in adolescents with depression 
include BMI, waist circumference, and abdominal fat, thus using the measurements of BMI 
and waist circumference in a preventive health checklist would be important in helping to 
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determine risk of cardiovascular co-morbidity. As only one study examined family history of 
CVD, it is difficult to gauge whether a family history of CVD is a significant risk factor to 
include in a preventive health checklist for adolescents with depression. However, other 
studies have examined family history in adults and determined it to be predictive enough of 
CVD to include in risk equations such as the FRE for cardiovascular risk. Three other 
potentially important risk factors that should be considered for inclusion in a preventive 
health checklist examining cardiovascular co-morbidity in adolescents with depression are 
insulin resistance, impaired fasting glucose, and increased triglycerides as several studies 
found these to be significant in this particular population as well.   
After a thorough review of the current literature, two things are clear: 1) there is a gap 
in the knowledge about the use of preventive health checklists in adolescents with depression 
to mitigate the future risks of CVD; and 2) there appears to be an association between 
depression and CVD even in adolescence. However, what is needed now is to know how this 
information can be translated into care? The purpose of understanding an association 
between disorders is to determine whether a causal relationship exists. By knowing if one 
condition causes another, healthcare providers can assist the patient to intervene in the 
disease process by mitigating or even preventing the secondary condition from developing. 
To assess and intervene in a disease, healthcare providers need to understand the signs and 
symptoms indicative of the disease, to both recognize its onset and also to ensure that 
appropriate health promotion and disease prevention strategies aimed specifically at 
changing the course of the disease are undertaken. Without the understanding of the cause, 
signs, or symptoms of a disease, a preventive health checklist cannot be created. This 
integrative review has provided some of the signs and symptoms that may indicate 
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cardiovascular dysfunction that may present in the adolescent with depression, providing not 
only an specific course for disease prevention and health promotion, but also for the creation 
of a preventive health checklist for primary care providers to follow when providing care to 
this population. By adequately screening, identifying, and treating depression in adolescents, 
healthcare providers may be able to reduce cardiovascular risks and prevent future 
cardiovascular morbidities.  
Review Limitations 
 There are limitations present in this integrative review. The evaluation and 
interpretation were completed by one person, potentially leading to errors in analysis. Also, it 
is acknowledged by the author that the specific question of whether preventive health 
checklists would improve later cardiovascular co-morbidities in adolescents living with 
depression has also not been directly addressed by the findings. Additionally, while 
preventive health checks are identified as being valuable when treating patients with mental 
health disorders and have evidence supporting their use within primary care, it was beyond 
the scope of this integrative review to determine whether PCPs are actually using preventive 
health checklists in practice or whether they find them useful for health screening in 
adolescents. It is recognized that these limitations are important in determining whether 
cardiovascular co-morbidities can be prevented in adolescents with depression.     
This review found several cardiovascular risk predictors that could be used as part of 
a preventive health checklist to assess for and potentially prevent CVD in adolescents with 
depression. The next section provides a discussion and synthesis of the findings derived from 
the eight studies examined in this review with recommendations for future practice and 
research.  
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CHAPTER FOUR 
Discussion and Recommendations 
 This integrative literature review was undertaken to determine if having preventive 
health checklists during primary care visits improve later cardiovascular co-morbidities for 
adolescents with depression. The seven non-experimental studies and one meta-analysis 
utilized in this review do not provide enough data to support the use of preventive health 
checklists in primary care to improve cardiovascular co-morbidities in adolescents with 
depression. While the literature did not directly address using preventive health checklists in 
adolescents with depression, it did find several physiological changes that occur in 
adolescents with depression, which may increase their individual risk for cardiovascular co-
morbidity and mortality. PCPs are well positioned to provide necessary screening, discuss 
risks, prevent illness, and counsel adolescents on their health as 70 percent of them visit their 
healthcare provider at least once every four years (Ham & Allen, 2012). Moreover, NPs 
provide primary care, have longer appointment times, and focus on health promotion and 
disease prevention, making the use of preventive health checklists well-suited for NP 
practice. A synthesis of the evidence will provide the necessary foundation to support 
recommendations for future practice as well as those factors that could possibly be used in a 
preventive health checklist for measurement of both screening for depression and potential 
cardiovascular co-morbidities in adolescents with depression.   
Gender, Diagnosis, and Clinical Measures in the Expression of Cardiovascular Risk  
The American Health Association recently recognized MDD as a moderate risk factor 
for accelerated atherosclerosis before the age of 30 (de Ferranti & Newburger, 2016a; 
Goldstein et al., 2015). Although more and stronger evidence is needed, the studies reviewed 
showed that adolescents with depression may be at higher risk of cardiovascular co-
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morbidities if they are female and they have: depressive symptoms by either clinical 
diagnosis or self-report; stiffer blood vessels as measured by faster PWV and shorter PTT; 
poorer endothelial functioning as evidenced by decreased nitric oxide production; widening 
or narrowing of vessel diameters; increased BMI; high fasting blood glucose levels; 
increased triglycerides; and insulin resistance. Currently, it is believed that these 
atherosclerotic vascular changes are minor and can be minimized or prevented if identified 
and reversed in time (de Ferranti & Newburger, 2016a). 
Having MDD places adolescents in a moderate risk category for CVD, however, this 
risk can be elevated to high risk with the addition of several risk factors, including: abnormal 
fasting lipids, hypertension, increased BMI, elevated fasting blood glucose, cigarette smoke 
exposure, sedentary lifestyle, and family history of early CVD (de Ferranti & Newburger, 
2016a). While CVD does not generally manifest as overt mortality and morbidity until 
adulthood, it is clear that the atherosclerotic process begins during the years of childhood and 
adolescence (de Ferranti & Newburger, 2016a). However, what is not clear, is the direction 
of the association between the risk factors identified in adolescents with depression. Is the 
elevated risk of CVD a result of simply having depression, or is it related to having prior 
traditional risk factors of CVD that lead to MDD, or is it because depression and CVD share 
similar genetic components making it more likely to have both co-morbidities? This review 
of the literature was also not able to answer this question given that none of the articles 
studied investigated genetic components of MDD and CVD with the exception of whether 
any of the study participants parents had a family history of CVD, which is a well established 
risk factor for CVD in the adult population.   
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Unfortunately, much of the evidence used in this integrative review that helped 
identify these cardiovascular risk predictors were from small, non-experimental grade B 
studies that were sometimes unable to show statistical significance due to low incidence of 
events, low numbers of participants, and most were not longitudinal. Thus, it is 
recommended that high-quality, longitudinal research be conducted following adolescents 
with depression well into adulthood in order to investigate the association between 
depression and these cardiovascular risk predictors. This relationship is important for health 
care providers to understand as it will allow for the identification of those adolescents with 
depression at highest risk of CVD due to atherosclerotic changes, as well as the much-needed 
evidence to support how to best mitigate such increased risk. Having a better understanding 
of the causal relationship will provide information that can be included in evidence-based 
screening tools, such as preventive health checklists, as well as imperative information on 
how to manage and treat such cardiovascular risk predictors in order to prevent future 
cardiovascular mortality. This integrative review has suggested that further understanding of 
the relationship, future significance, morbidity, and mortality of cardiovascular risk 
predictors in adolescents with depression is needed before creating a preventive health 
checklist. Therefore, a recommendation from this review is the creation of high quality, 
longitudinal evidence evaluating the cardiovascular risk predictors in children, youth, and 
adults with depression that can potentially be used to create a preventive health checklist for 
use in adolescents with depression.  
Preventive Health Checklists 
Preventive health checklists and screening tools are used to identify patients at 
increased risk of disease even if they appear to look healthy. Preventive health care and 
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screening tools are both recommended and developed by the Canadian Task Force on 
Preventive Health Care (CTFPHC), which appraises and synthesizes the most current 
literature in order to disseminate evidence-based preventive health guidelines into primary 
care practice. There are certain characteristics that make a disease a good candidate for 
screening, this includes substantial morbidity and mortality if the disease goes untreated, 
high prevalence of the disease, the existence of the disease is detectable, a cost -effective 
treatment is available, and preclinical detection of the disease improves prognosis and 
management (Kelly, 2016). Cardiovascular disease has both a high rate of prevalence as well 
as significant morbidity and mortality if not detected early, given that depression is a 
moderate risk factor of CVD, it makes sense that there be a screening test to detect CVD in 
adolescents with depression. 
In order for the CTFPHC to publish preventive health guidelines they must first 
develop analytic frameworks, review scientific literature, synthesize scientific evidence, 
perform analyses of decisions and cost, obtain peer feedback from experts, write reports to 
summarize evidence, translate evidence-based knowledge into clinical practice, conduct 
systematic reviews, develop and implement evidence-based tools to improve clinical 
practice, identify gaps in the literature and ways to address these gaps, and publish results of 
the guidelines for public use (CTFPHC, 2016). Moreover, screening tests need to be easy to 
perform and interpret, measurable, have low risk, morbidity, and cost as well as be highly 
sensitive and specific (Kelly, 2016). Thus, with any preventive health screening conducted in 
primary care, there must be parameters to define who is screened, when they are screened, 
why they are screened, what they are being screened for (the disease or illness being 
prevented), and the method for screening (the tool to be used). Without the use of such 
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parameters the process of providing preventive health screening for every patient for every 
possible disease and illness would become overwhelming for healthcare providers and risk 
either over-estimating patients’ risk for disease or failing to complete any preventive health 
screening due to time limitations of screening so many patients. As well preventive health 
checklists need to be based on high grade evidence that clearly shows positive health benefits 
to cost ratio, as well as exactly which risk factors contribute the highest, most reliable, and 
most predictive risk of cardiovascular co-morbidity in order for those factors to be weighted 
and thus provide an accurate prediction of risk over time. 
Adherence to recommended preventive health screening by PCPs is lowest for the 
adolescent population, even though preventive health screenings are warranted as tools that 
significantly increase life expectancy at no increased cost to the healthcare system (De Hert, 
Dobbelaere, Sheridan, Cohen, and Correll, 2011; Ham & Allen, 2012; Rasmussen, Thomsen, 
Kilsmark, Hvenegaard, Engberg, Lauritzen & Sogaard, 2007). This lack of provider 
adherence is due to factors such as a deficiency of evidence supporting specific health 
screening and behaviour counselling; lack of time to deliver preventive health 
recommendations; lack of healthcare provider confidence in behaviour modification skills; 
lack of guidelines for how often recommended screening should occur; and the perceived 
lack of interest for disease prevention and behaviour change from adolescents (Ham & Allen, 
2012). However, preventive health screening in adolescence is necessary to help prevent and 
decrease the rates of mortality and chronic conditions, some would even argue it is more 
important and also better done in the adolescent period before both permanent health and 
physiologic changes can develop. Yet most preventive health checklists and screening tools 
are developed for use during adulthood a period of time when significant behaviour and 
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health changes are harder to make and more chronic and genetic changes are likely to occur, 
perhaps making it more difficult to actually change the course of a disease. Thus, it is the 
recommendation of this review that more emphasis be put on prevention during the 
adolescent period by creating preventive health checklists to predict health risk and 
supporting providers to implement early behaviour modification counselling.   
This integrative review revealed several factors present in adolescents with depression 
that could be predictive of cardiovascular co-morbidities and thus could potentially be used 
as part of a preventive health checklist. Yet, while this review has added some much-needed 
evidence supporting the creation of a preventive health checklist in adolescents with 
depression to predict cardiovascular co-morbidity, more high-quality research on the 
outcomes of depression in adolescents is needed. By identifying these specific evidence-
based risk predictors and how to best screen for these risks, preventive health screening 
recommendations can be prioritized and narrowed to include only the relevant parameters. 
This would allow PCPs to focus their valuable time on preventive health services and 
behavioural counselling that are going to result in positive health outcomes for these 
adolescents with depression. Additionally, by prioritizing and narrowing the scope of 
screening, PCPs are reassured that they can provide these preventive health services within 
the time constraints of busy office visits. Further, this review provides evidence for PCPs 
showing the importance of integrating preventive health screening into adolescent primary 
care visits as well as the need for a screening tool that includes all the important information 
in one convenient tool that can be used in daily, routine clinical practice. There remains a 
gap in the knowledge to answer the question of whether preventive health checklists help 
prevent cardiovascular co-morbidity in adolescents with depression, including not only a lack 
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of high quality evidence on which to base preventive health screening, but also an easy-to-
use tool with which to actually perform the screening. Thus, it is the recommendation of this 
integrative review that after collection of high-quality evidence, the CTFPHC develop 
guidelines as well as a quick, easy, and evidence-based preventive health checklist for the 
evaluation of cardiovascular health in adolescents with depression, as well as how often the 
recommended screening should occur and any specific health behaviour counselling that 
PCPs can use within office appointments. With such significant changes to screening and 
prevention guidelines appropriate education communicating those changes should be offered 
to those healthcare providers caring for youth, thus helping boost their confidence in 
screening and behaviour modification skills. 
Treatment and Management Recommendations for Adolescents with Depression 
 Preventive health checklists will help identify adolescents with depression who are at 
risk of cardiovascular co-morbidity, but will not address how to treat or manage these 
cardiovascular co-morbidities in adolescents. There is little evidence regarding the outcomes 
of depression in adolescents, there is also very little evidence about the management of 
preventing cardiovascular co-morbidities. Thus, there is a need for not only further research 
on cardiovascular outcomes in adolescents with depression, but also prevention strategies, 
treatment, and management of the potential consequences as well. However, it stands to 
reason that adolescents with depression would benefit from the same prevention strategies 
that are recommended for either adults with cardiovascular risk factors or other adolescents 
with identified metabolic symptoms. One primary care strategy currently in use to assist 
PCPs with the screening, management, and treatment of adolescents is to establish a strong 
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therapeutic relationship and to actively seek collaboration with community programs that 
specifically address adolescent health issues (Ham & Allen, 2012).  
This collaborative strategy should be supported for use in primary care for 
adolescents with depression at risk of cardiovascular disease as medical interventions are 
lacking and until there is more evidence-based information, a team approach including 
behaviour, nutritional, and emotional therapy is likely most beneficial (Ham & Allen, 2012). 
One such team approach program currently exists at BC Children’s Hospital Provincial 
Mental Health Metabolic Program (Provincial Health Services Authority [PHSA], 2017). 
This program is geared toward providing screening, education, medical management and 
assessment, as well as monitoring and follow up for youth with metabolic symptoms 
including central weight gain, high blood sugar, hypertension, increased lipids, insulin 
resistance, and elevated triglycerides (PHSA, 2017). Currently the clinic accepts referrals for 
youth who have any one of the following: risk of developing metabolic conditions but who 
need to be treated with an second-generation antipsychotic (SGA); already developed 
metabolic side effects during treatment with SGA; metabolic conditions and require mental 
health support (PHSA, 2017). A team consisting of a child psychiatrist, pediatric 
endocrinologist, dietician, lifestyle coach, nurse practitioner, physiotherapist, and 
pediatrician work with youth to manage their metabolic side effects through healthy eating, 
physical activity, stress management, and improving their sleep habits (PHSA, 2017). This 
program focuses primarily on assessing, treating, and managing metabolic syndrome caused 
by SGA in youth. However, as this integrative review has shown, adolescents with 
depression also suffer from many of the same symptoms of metabolic syndrome including 
insulin resistance, elevated fasting blood glucose, and elevated BMI. Thus, it is the 
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recommendation of this integrative review that this program be adapted or expanded to 
include the ever-increasing numbers of adolescents with depression. Such a program will 
provide the much-needed multidisciplinary team approach that focuses on healthy eating, 
physical activity, stress management, and healthy sleep habits to mitigate the cardiovascular 
co-morbidities that many adolescents with depression share with these adolescents taking 
SGA.  
Further, it may be worth noting that creating and disseminating high-quality evidence 
and guidelines takes time, time that some adolescents struggling with depression and 
physiologic cardiovascular changes may not have. Thus, PCPs may want to consider 
borrowing strategies from other similar groups of adolescents to provide evidence-based 
recommendations for monitoring, screening, and managing such patients until more research 
can be done. This writer suggests looking at the body of evidence, including not only what 
has been presented in this review, but also that related to adolescents taking SGA who 
experience cardiometabolic changes, in order to provide current information to PCPs about 
how to best provide care for those adolescents with depression. Correll (2008) suggests the 
following health strategies for adolescents with metabolic syndrome caused by SGA: 1) 
Primary prevention – education on healthy lifestyle and how to maximize adherence to 
healthy behaviours including limiting sugary beverages; regularly eating breakfast; endorsing 
frequent small meals; avoid meals with high levels of processing, sugar or fat ; increasing 
soluble fibre; limiting sedentary activity by reducing screen time to two hours or less a day; 
and promoting at least an hour of physical activity per day; 2) Secondary prevention – for 
those that have mild metabolic abnormalities or significant increase in BMI, it is suggested 
that the above lifestyle instructions be intensified and a non-pharmacological weight loss 
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treatment be started; 3) Tertiary prevention – for those that have hyperglycemia, 
dyslipidemia, or hypertension, it is recommended that weight reduction interventions be 
intensified and treatments be targeted to metabolic or endocrine abnormalities in conjunction 
with pediatric specialists.  
While increased BMI has been identified as the strongest predictor of cardiovascular 
risk in the literature and was found by this review to be strongly associated with 
cardiovascular disease particularly in adolescents with depression, it is only one part of the 
equation when assessing for risk. As is the case with any screening tool or risk prediction 
tool, multiple factors need to be taken into account in order to have a better understanding of 
what is going on. As it was noted earlier, elevated BMI is a better cardiovascular risk 
predictor when it is included with at least three other signs of dysfunction, and in the case of 
the adoescent with depression this would include hypertension, dyslipidemia, and insulin 
resistance or increased fasting glucose. However, simply having an increased BMI does not 
mean that cardiovascular risk is inferred, just as having a low or average BMI does not mean 
that risk is averted, these measurements in and of themselves are just that, measurements. To 
calculate risk the entire person needs to be taken into consideration and risk should be 
predicted based on the individual, just as their treatment and management is tailored and 
individualized to what is important and meaningful for that patient. Today there is increasing 
peer, media, and societal pressures for adolescents about weight, whereby being thin is 
emphasized and exemplified as the ideal while being overweight or obese is considered 
undesirable and unhealthy. It is not the intention of these recommendations to further 
perpetuate this psychosocial stigma but instead to acknowledge that an elevated BMI may be 
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a cardiovascular risk predictor in adolescents with depression and as such may need to be 
assessed, monitored, or managed as per the individual’s risk and personal health status.    
Therefore, it is a recommendation of this review that adolescents with depression at 
risk of CVD be educated on the above provided primary prevention strategies. Secondary 
prevention should be considered for adolescents with psychiatric illness in the following 
situations: BMI is greater than the 95th percentile or waist circumference is greater than the 
90th percentile; there is a seven percent or higher weight gain over three months; or BMI is 
between 85-94.9 percentile and there is one adverse health consequence such as 
hyperglycemia, dyslipidemia, hyperinsulinemia, hypertension, sleep disorder, orthopedic 
problems or gall bladder disease (Correll, 2008). Adolescents that require secondary 
prevention should have more intensive medical treatment implemented by their PCPs 
including increased monitoring of screen time less than an hour each day, supervised 
physical activity of at least an hour each day, structured dietary intake, and goal setting 
(Correll, 2008) with the overall goal of creating healthy habits that prevents disease and 
promotes health. Additionally, management of the adolescent with depression should include 
assessing mood and depressive symptoms, asking about any suicidal intentions, monitoring 
vital signs for changes to BP and heart rate, and considering the need for bloodwork to assess 
for increased fasting blood glucose and dyslipidemia at a minimum of once a year. If after 
secondary prevention there continues to be a worsening of bloodwork or vital signs, a 
referral to a multidisciplinary team such as the Provincial Mental Health Metabolic Program 
should be strongly encouraged. Moreover, more current and relevant research is needed to 
determine whether these management strategies are clinically useful in adolescents with 
depression to prevent cardiovascular co-morbidities.      
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In addition to management strategies, it is a suggestion of this review that routine 
monitoring be done in order to detect emerging problems early. The need for monitoring to 
prevent CVD in children and adolescents has been acknowledged within European 
psychiatric literature, however, specific guidelines for this population have not yet been 
formulated (De Hert et al., 2011). Furthermore, Correll (2008) and De Hert et al. (2011) have 
made recommendations for the monitoring of weight gain and metabolic side effects in 
adolescents taking SGA that includes: personal and family medical history at baseline and 
then annually; review of lifestyle modifications at baseline and then every three months; 
height, weight, and calculation of BMI at baseline and then every three months; blood 
pressure, heart rate, fasting blood glucose, and lipids at baseline, three months and then every 
six months; all of these measurements should continue unless abnormalities are detected. 
Therefore, it is suggested that further research be done to evaluate and create evidence-based 
monitoring guidelines. However, until such research is complete, at least annual review of 
lifestyle modifications, vital signs, weight, height, fasting blood glucose and lipids  should be 
considered in adolescents with depression to minimize and hopefully prevent future 
cardiometabolic consequences.  
Finally, more research is needed to understand the effect of standard non-
pharmacological treatments (consistent parenting and normalizing routines of sleep, eating, 
and physical exercise) on preventing cardiovascular comorbidities in adolescents with 
depression. Such research on adolescents with depression should be extended to include both 
the effects of pharmacological treatment with fluoxetine and the psychotherapeutic 
interventions of cognitive behavioural therapy and interpersonal therapy on the prevention of 
future morbidity and mortality. A promising longitudinal, randomized controlled trial 
74 
 
investigating the effects of cognitive behaviour therapy and mindfulness-based sleep 
intervention on preventing depression and improving cardiac health is currently being 
conducted in Melbourne, Australia (Waloszek et al., 2015b). This Sleep and Education: 
Learning New Skills Early (SENSE) study is due to finish in later 2017, after a two-year 
follow-up with participants has been completed and will hopefully represent a significant 
piece of research supporting treatment of adolescent depression and cardiovascular health but 
also add important evidence to the already existing body of evidence outlining the 
relationship between depression, sleep, and cardiovascular health. More research is needed to 
add meaningful and significant discussion about adolescent depression and the devastating 
sequelae that can occur as a result. Until that time, it is the recommendation of this review 
that PCPs continue to help diminish the effects of depression by both counselling patients 
about the standard non-pharmacological treatments and, in accordance with the standards and 
scope of practice of the provider, treatment with medications such as fluoxetine as well. 
Thus, by properly treating and addressing adolescent depression, hopefully later 
cardiovascular co-morbidities can be prevented or minimized.   
Thus, while this integrative review was unable to provide the answer about whether 
preventive health checklists can decrease future cardiovascular co-morbidities in adolescents 
with depression, several other important recommendations can be made, as seen summarized 
in Table 4.  
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Table 4: Summary of Recommendations 
Research 
1) High-quality, longitudinal research needs to be conducted on adolescents with depression as they 
transition into adulthood, investigating the causal relationship between depression and 
cardiovascular risk predictors, to understand how to screen, manage, and treat both co-morbidities 
Prevention 
2) Creation of a quick, easy-to-use preventive health checklists based on high grade evidence that 
clearly show positive health benefits to cost ratio, as well as the parameters for who should be 
screened, when, why, and what they should be screened for; that is, exactly which risk factors 
contribute the highest, most reliable, and most predictive risk of cardiovascular co-morbidity in 
order for those factors to be weighted and thus provide an accurate prediction of risk over time 
Education 
3) More education and training of PCPs on preventing CVD in adolescents with depression and 
supporting providers to implement early behaviour modification counselling to mitigate these risks 
Treatment and Management 
4) A multidisciplinary approach should be used to promote disease prevention and health promotion 
in adolescents with depression which focuses on healthy eating, physical activity, stress 
management, and healthy sleep habits to mitigate their cardiovascular co-morbidities 
5) Implementation of primary prevention strategies including education on healthy lifestyle and how 
to maximize adherence to healthy behaviours including limiting sugary beverages; regularly eating 
breakfast; endorsing frequent small meals; avoid meals with high levels of processing, sugar or fat; 
increasing soluble fibre; limiting sedentary activity by reducing screen time to two hours or less a 
day; and promoting at least an hour of physical activity per day for all adolescents with depression  
6) Monitoring of weight gain and metabolic side effects in adolescents with depression should 
include: personal and family medical history at baseline and then annually; review of lifestyle 
modifications at baseline and then every three months; height, weight, and calculation of BMI at 
baseline and then every three months; blood pressure, heart rate, fasting blood glucose, and lipids 
at baseline, three months and then every six months; all of these measurements should continue 
unless abnormalities are detected 
7) PCPs continue to help diminish the effects of depression by both counselling patients about 
standard non-pharmacological treatments such as sleep, exercise, CBT, counselling, and diet as 
well as the use of medications such as fluoxetine until more research can be done to support which 
treatments are most effective at mitigating cardiovascular risk 
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CHAPTER FIVE 
Conclusion 
Adolescent depression can have many devastating effects on the developing youth, 
including significant disability and cardiovascular morbidity. As future primary care 
providers, it is our responsibility to educate both ourselves and our adolescent patients about 
such risks and help them mitigate and prevent those risks from negatively impacting their 
young lives. Although the evidence was not robust, this review has suggested that 
adolescents with depression are at risk for stiffer blood vessels as measured by faster PWV 
and shorter PTT, poorer endothelial functioning as evidenced by decreased nitric oxide 
production, widening or narrowing of vessel diameters, increased BMI, high fasting blood 
glucose levels, increased triglycerides, and insulin resistance, all of which contribute to a 
higher risk of cardiovascular co-morbidity and mortality. The risk of adolescent depression 
has been identified by the American Heart Association as a moderate risk factor for 
cardiovascular disease and yet there have been no recommendations put forth to practitioners 
about how to address this risk. While this integrative review was not able to answer the 
question whether preventive health checklists decrease cardiovascular risk in adolescents 
with depression, several recommendations have been made to assist primary care providers 
in predicting, preventing, and mitigating the cardiovascular risks until more high-quality 
longitudinal epidemiological studies and research can be done investigating the causal 
relationship between depression and cardiovascular disease in adolescents. Until such time as 
evidence-based guidelines can be made, the recommendation coming from this review is that 
practitioners use a multidisciplinary approach for adolescents with depression that includes 
education on diet, exercise, and sleep, as well as regular monitoring of BMI and bloodwork.   
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Glossary 
All citations from Medical Dictionary (Merriam-Webster, 2015) unless otherwise indicated. 
 
adolescence: the period of life from puberty to maturity terminating legally at the age of 
majority 
anhedonia: psychological condition characterized by inability to experience pleasure in 
normally pleasurable acts 
atherosclerosis: a chronic disease characterized by fatty deposits and fibrosis causing 
abnormal thickening and hardening of the inner layer of the arterial walls   
body mass index: a measure of body fat that is the ratio of weight in kilograms to the square 
of the body’s height in meters 
bradycardia: relatively slow heart action 
caliber: the diameter of a round or cylindrical body 
cognitive behavioural therapy: psychotherapy that combines cognitive and behavioural 
therapy by identifying faulty or maladaptive patterns of thinking, behaviour, or emotional 
response and substituting them with desirable patterns of thinking, behaviour, or emotional 
response 
endothelium: a cellular tissue composed of a single layer of thin flattened cells that lines 
internal body cavities and blood vessels 
hazard ratio: a comparison between the probability of events in a treatment group, 
compared to the probability of events in a control group, used primarily to determine if 
treatment progress is faster or slower than those not receiving treatment (Statistics How To, 
2017a) 
heterogenous: consisting of dissimilar or diverse ingredients or constituents 
interpersonal therapy: psychotherapy that focuses on a patient’s interpersonal relationships, 
it is particularly useful in treating patients with depression 
ischemic heart disease: disease caused by narrowed cardiac arteries, which restricts blood 
flow and oxygen to the cardiac muscle and includes acute myocardial infarction and 
atherosclerotic cardiovascular disease (American Heart Association, 2016) 
myocardial infarction: an acute episode of ischemic heart disease marked by the death or 
damage of heart muscle due to insufficient blood supply to the heart muscle usually as a 
result of a coronary artery becoming blocked by a blood clot formed in response to a 
ruptured or torn fatty arterial deposit 
nurse practitioner: a registered nurse who is qualified through advanced training to assume 
some of the duties and responsibilities formerly assumed only by a physician 
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plaque: an atherosclerotic lesion 
plethysmography: an instrument for determining and registering variations in the size of an 
organ or limb resulting from changes in the amount of blood present or passing through it  
power of analysis: determines the sample size required to detect an effect within a sample 
with a given degree of confidence (Kabacoff, 2017) 
retinal artery: a branch of the ophthalmic artery that passes to the retina in the middle of the 
optic nerve and branches to form the arterioles of the retina  
second generation antipsychotic: class of medication used to treat some mental health 
conditions such as pervasive developmental disorders, disruptive behaviour disorders, and 
obsessive-compulsive disorders that have a more favourable neuromotor side-effect profile 
with fewer extrapyramidal adverse effects than first generation antipsychotics (De Hert et al., 
2011) 
sensitivity: proportion of people with the disease who will have a positive test result  
(Statistics How To, 2017b) 
specificity: proportion of people without the disease who will have a negative test result 
(Statistics How To, 2017b) 
somatic: of, relating to, or affecting the body 
statistical significance: a result from testing that is likely not to have occurred randomly or 
by chance, but is likely to be attributable to a specific cause, commonly expressed as the p 
value  
systolic blood pressure: the highest arterial blood pressure of a cardiac cycle occurring 
immediately after systole of the left ventricle of the heart 
triglycerides: any of a group of lipids which are widespread in adipose tissue and commonly 
circulate in the blood 
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Figure 1: Flowchart of articles  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Abstraction journals, 
electronic databases, grey 
literature 
n = 67,674 
Number of articles excluded 
per exclusion criteria 
n = 67, 621 
Number of articles after 
screening (relevant to topic) 
n = 53 
Read full articles and use 
inclusion and exclusion 
criteria 
n = 15 
Number of articles 
excluded due to 
inappropriate subject age, 
publication greater than 10 
years old, not original 
research and duplication 
n =7 
Number of total articles 
included in integrative 
review 
n = 8 
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